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vAbstract
This thesis is divided into three sections all pertaining to microarray experimental
design and analysis. Microarrays are a tool used in biological research which enables
scientists to measure the relative level of expression many genes within an organism at
the same time. Microarrays have also opened new research areas in statistics which are
currently being investigated concerning different aspects of data normalization, experi-
mental design, and analysis.
The first chapter entails a comparison of two commonly used experimental designs
in two-dye microarray experiments. Both designs are applicable only to experiments
containing treatments with two levels. One design is shown to be more powerful when
constrained by the number of arrays. Also, mixed model analysis is often used for both
designs. With small sample sizes, mixed model analysis is shown to give inaccurate
results under certain conditions. Due to this problem, an alternative method of analysis
is proposed for both experimental designs which eliminates this concern.
Two-dye microarray experiments require special consideration in design since they
have multiple random effect in the model. This is because arrays are usually viewed as
a random factor that should always be contained in a model for the data. Research has
been done on comparing two-dye microarray experimental designs by requiring calcula-
tion of array differences. This is shown to inhibit the power of the analysis by removing
inter-block information. There are also experimental designs that are viable options
which can not be compared using this method. An alternative method of analysis is
proposed which allows for multiple random effects in the model. Under certain condi-
vi
tions, this method is shown to choose designs that either would not be chosen, or cannot
be considered, when using methods based on array differences.
The third chapter discusses new methods for analyzing microarray experiments by
categories. Most commonly, microarray analysis is performed on a gene-by-gene basis
with the goal of finding the genes whose expression differ the greatest between varieties
of treatments. However, scientists often would like to know what aspect of cell life
is affected most by differences in varieties. There could be cases where a group of
genes pertaining to the same task are all have a mild change in expression which would
not be found using gene-by-gene analysis. Two different resampling based methods are
proposed for solving this problem. Both methods are compared and results are visualized
on a directed acyclical graph.
1General Introduction
1 Microarrays
1.1 Cell life
Microarrays can be used to approximate the protein production of the genes ex-
pressed within the cells of an organism. Gene expression determines the actions of a
cell and how it interacts with its neighboring cells. Within the nucleus of all cells of
both plants and animals, is deoxyribonucleic acid (DNA) which can be viewed as a long
linear sequence of bases. This sequence is responsible for hereditary traits passed down
to offspring. The DNA is distributed among long linear structures called chromosomes.
There can be 1 to more than 50 chromosomes within an organism. The size and the
number of chromosomes is the same in each cell of an organism but varies among dif-
ferent organisms. Within DNA, a total of four different bases can be found. They are
adenine(A), cytosine(C), guanine(G), and thymine(T). Due to their chemical structure,
A will bind to T and C will bind to G. This is important because a sequence of bases will
have chemical attraction to its complement. For example if the sequence of one strand
is · · ·A-G-C-A· · · than its complement strand is · · ·T-C-G-T· · · and these sequences
would naturally bind to each other.
Certain regions of the chromosome are referred to as genes. Within genes, specific
base sequence code for specific protein(s). Proteins account for almost all cellular activity
while also forming the key elements of a cell, such as the cell walls in plants. The process
2of creating proteins from genes is the central dogma of molecular biology and consists
of two stages: transcription and translation. Through transcription, mRNA, which is
also a sequence of bases, is created. The mRNA is the complement to the gene sequence
except that the base thymine, is replaced by uracil (U). An example of transcription is
shown in Figure 1.
Figure 1 Transcription.
The mRNA is then converted to the corresponding protein through a process called
translation. A protein is a three dimensional structure consisting of a sequence of amino
acids. In mRNA, a sequence of three bases indicates one amino acid. After translation,
there is approximately one third the number of amino acids in the protein as there are
bases in the mRNA. An example of translation is shown in Figure 2.
Figure 2 Translation. AAi indicates an amino acid.
The preceding examples are oversimplified. In organisms, such as humans, a chro-
mosome is millions of base pairs long while gene sequences are usually thousands of
bases long. More than one protein can be made from a single gene sequence and a large
number of mRNA sequences can be translated simultaneously. Different types of cells
within the same organism, such as skin cells and bone cells, will express different genes,
enabling the cell to perform the correct duties. Cells affected by a stress, such as a
disease, will usually change their normal expression patterns. Learning what genes are
3expressed in an organism resistant to a disease versus a similar organism that is suscep-
tible can give valuable information toward deriving a cure. This is just one example but
there are many other ways in which genome expression information is useful.
Microarray experiments measure the amount of mRNA that is currently present
within the cells of the organism that is sampled. Measuring the mRNA does not give a
direct measure of the amount of protein being produced because translation is necessary
for the protein to be created. It has been shown that mRNA can be transcribed without
being translated. However, research has also shown that the amount of mRNA present
can give a good estimate of the amount of protein being produced (Lodish et al., 2000).
When performing microarray experiments, the mRNA removed from the cells of an
experimental unit has to be synthesized to complementary DNA (cDNA). The cDNA is
complementary to the mRNA sequence except that where there would be uracil(U) in
a complementary mRNA sequence, there is now thymine(T). Converting the mRNA to
cDNA makes the sample more chemically stable which creates more consistency in the
experimental results.
1.2 Spotted Microarrays
The spotted microarray, or two-channel microarray, is a glass slide containing a large
number of small spots. There can be more than 30,000 spots for different genes on a
single array. Each spot contains a large number of identical strands that are usually
200-1000 bases long. These strands are made so that they are complementary to the
cDNA for a specific gene created from the original mRNA sample. At every spot, a
large number of strands which are complementary to a specific gene are applied. The
complementary nature of the strands enable the cDNA for that gene to attract to and
bind with the strands on the microarray slide. The cDNA from a sample is labeled with
a fluorophore, or dye. There are two different colored dyes used in an experiment. One
is usually red and the other green. Using different dyes enables the measurement of two
4different samples on the same array. Measurements are obtained by exciting the samples
with a laser and measuring both the green and red fluorescence at each spot.
As an example, assume there is to be a study analyzing gene expression differences
between cells from a person with cancer versus another one without cancer. First,
mRNA samples would be taken from each subject. The mRNA would then be converted
to cDNA and the red dye would be applied to the sample from the cancer subject while
the green dye would be applied to the sample from the subject without cancer. Both
dyed samples would then be hybridized to the microarray. Each spot would then be
excited by a laser and measurements would be obtained for each gene and each dye. An
example of an array is shown in Figure 3.
Figure 3 A spotted microarray. Bright colors indicate high expression lev-
els, while dark colors indicate low expression levels. The red spots
indicate expression predominantly in the subject receiving the red
dye while green spots indicate the opposite. Yellow spots indicate
roughly equal expression levels.
5A problem found when working with spotted microarrays is that the intensity mea-
surement is biased depending upon the dye. A larger measurement can be obtained
from one dye versus the other for the same amount of cDNA. Because this is consid-
ered a global effect and is introduced because of technical difficulties, normalization is
often used prior to the analysis to remove the dye bias. There have been many methods
proposed for normalization of the data (Wolfinger et al., 2001 ), many of which involve
some form of loess regression (Smyth and Speed, 2003; Yang et al., 2002). The analysis
is then performed on the data resulting from the normalization.
1.3 Oligonucleotide Microarrays
Oligonucleotide microarrays are created using different procedures than those used
for spotted arrays. DNA oligonucleotides, which are short sequences of about 25 bases,
are synthesized to the surface of a glass slide. The DNA oligonucleotides are created to
be complementary to a gene sequence region that is unique. The uniqueness is necessary
so that only the sequence of the gene of interest will bind to the oligonucleotides and
no other. Probes contain tens of thousands of identical oligonucleotides placed within
small square areas on the slide. Each gene will have several different probes and each
will be complementary to a different portion of the gene sequence. These probes for one
gene are placed on different regions of the slide. The mRNA samples are then tagged
with a fluorescent dye and applied to the slides. The quantity is measured by shining a
laser upon each probe and the florescence of the tagged samples is then calculated. An
example of an oligonucleotide microarray is shown in Figure 4.
When using oligonucleotide microarrays, researchers obtain a probe set of observa-
tions for each gene as opposed to one measure. There is concern for a possible bias
being added to the measurements of each probe according to their location. Methods
such as MAS 5.0 (Affymetrix) and RMA (Irizarry et al., 2003) have been proposed to
remedy these concerns. One of these normalization methods is chosen for use prior to
6Figure 4 Affymetrix oligonucleotide microarray. Each square represent one
DNA oligonucleotide. Brighter colors indicate a larger quantity
binding to the sequence.
the analysis to condense the data and minimize any bias that could be introduced be-
cause of technical difficulties. Analysis is then performed on the values received after
normalization.
2 Gene Ontology Consortium
The Gene Ontology Consortium was started in 1998 at www.geneontology.org with
the goal of aiding in the efficiency of scientific research (Gene Ontology, 2000). A problem
biologists can have is finding information of other scientists that pertains to their special
research area. Additional problems were generated by inconsistent terminology making
information even more difficult to find and share. Gene Ontology (GO) is a collaborative
effort to create consistent descriptions of gene products throughout different databases.
7GO has developed three separate ontologies or vocabularies which are: biological
processes, cellular components and molecular functions. Each ontology is designed to
describe gene products in a species-independent manner. The goal of making GO ter-
minology species-independent is because different organisms have large numbers of gene
products which accomplish similar tasks. Information can be obtained about the gene
product in the organism being studied by its similarity to gene products of other organ-
isms. The biological processes ontology is “a series of events accomplished by one or
more ordered assemblies of molecular functions.” (Gene Ontology, 2000) The molecular
functions is defined to be “the action characteristic of a gene product.”(Gene Ontology,
2000) The molecular functions and the biological processes do overlap and so there is a
rule that the biological processes must have more than one distinct step to help separate
them. The cellular component is the part of the cell that the gene product is active
within.
Each GO term in each ontology is associated with a unique numerical identifier of
the form GO:xxxxxxx, where the x’s indicate a 7 digit number. Each term also usually
has a definition. Every ontology relates the terms, or GO numbers, through a directed
acyclic graph. This graph is the same as a phylogenic tree except that a child node can
have more than one parent as shown in Figure 2.
The GO Consortium can be used in analyzing microarray experiments where data
is usually analyzed on a gene by gene basis. In these experiments, scientists are often
looking for networks consisting of many genes to explain biological differences. They can
investigate the list of genes whose null hypothesis, of equal expression levels amongst
the varieties, are rejected under some criterion and try to associate a network through
this list. However, there could be a family of genes, many with relatively small mean
differences, that are all having expression changes and could hold valuable information.
Since many of the genes within such a family will have small mean differences, most or
even all of them may not appear on the list of genes declared to have significant mean
8Figure 5 One region of the molecular function hierarchy with the broad-
est point at the bottom and specificity increasing going upward.
Each node contains its GO number and has arrows pointing at its
ancestor. Nodes colored orange have more than one ancestor.
differences. The family of genes could then go undetected. Alternatively, tests could be
performed by the GO categories instead of by the gene. Analysis using this perspective
could be used to investigate the entire family simultaneously, giving additional power to
finding groupings or families of genes which would not be discovered otherwise.
3 Dissertation Organization
There are three separate sections to this dissertation addressing three issues sur-
rounding microarrays. In Chapter 2, we deal with an experimental design commonly
called the reverse dye design and a comparison with an alternative design. Both designs
are for experiments where there are only two varieties, or treatment levels. An alterna-
tive design is shown to be more powerful, when constrained by the number of arrays,
through variance comparison as well as an actual experiment performed twice, once us-
ing each design. Also, mixed model analysis is often used in both designs even when the
size of the experiment is small. This leaves a large number of random effects relative to
the number of observations which is shown to return untrustworthy results. Alternative
9analysis methods are proposed for both designs which eliminates this problem.
In Chapter 3, we investigate mixed model analysis is commonly used in microarray
data analysis due to the experimental designs. When using spotted two-dye arrays, it
could be argued that mixed model analysis should have to be used for two reasons. It has
been shown that array effects can be gene specific (Kerr, 2003), thus requiring them to
be included in the model for each gene. Arrays, or slides, are usually viewed as random
effects because an experiment is commonly performed by purchasing arrays containing
sequences specific to the organism of interest. Usually, many other experiments are be-
ing performed on other arrays containing the same sequences. This enables the arrays
to be viewed as a random sample from a large population indicating that they should
be modeled as a random factor. Mixed model analysis is required to correctly handle
this. However, there have been many methods proposed in the past to compare fixed
effects only models. Various researchers have proposed reducing the data by calculating
the differences between the observations from a common array and then analyzing the
differences instead of the observed values (Kerr and Churchill, 2001; Yang and Speed,
2002; Glonek and Soloman, 2004). This enables comparison of designs by the fixed
effects only methods. However, analyzing the differences is shown to result in a loss of
power in certain circumstances. It is shown here that to maximize the power, mixed
model analysis should be used. If mixed model analysis is going to be used, then the
experimental designs should be compared under these conditions to get correct results.
A method of experimental design comparison which compares designs based upon the
mixed model requirements is proposed. This method allows more models to be consid-
ered, accounts for multiple random effects, and is shown to possibly result in different
design selections than the alternative methods.
In Chapter 4, we propose an alternative to the usual gene-by-gene analysis performed
on microarray experiments. Gene-by-gene analysis leaves researchers with a list of genes
to continue further research with after the microarray experiment. An alternative would
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be to group the genes based upon their molecular functions, and test this group or
category for differential expression between the treatments or varieties. This method
would leave scientists with a list of genes to research as well as additional information
about molecular functions operating differently between the varieties. There could also
be cases where an entire category of genes all change expression between the varieties,
but do so at a relatively small magnitude. None of these genes may be found by testing
each gene independently. Situations like this would be found when alternatively testing
the category. Two different methods for testing gene categories using resampling are
proposed. One method deals with the multivariate distribution of the data while the
alternative uses comparative measures of the p-values from every gene within a category.
Each method has specific situations where one would be preferred over the other. In
this dissertation, both methods are used in an example and compared.
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Design and Analysis of Two-Variety Two-Dye Microarray
Experiments for the Detection of Differentially Expressed
Genes
Justin C. Recknor and Dan Nettleton
Abstract The reverse dye design has often been used in spotted two-dye
microarray experiments when there are only two varieties being studied.
An alternative design is shown to be more powerful when the defining
factor is the number of arrays through an actual experiment and simu-
lation. The data from either design can be analyzed using mixed model
analysis, but we show through simulation that the resultsing tests can be
too conservative or too liberal when model variance components are esti-
mated to be zero. We show that this problem is eliminated by a simple
alternative analysis strategy in which the data from each spot are reduced
to a difference prior to the analysis.
1 Introduction
Over the past decade, two-dye microarray technology has become a standard tool
in functional genomics research. Researchers use two-dye microarrays to measure gene
13
expression changes across biological samples of multiple types. By understanding how
specific genes change expression across carefully selected sample varieties, researchers
gain information about the role of genes in important biological processes.
A single two-dye microarray slide can be used to measure the expression of thousands
of genes in each of two samples. The samples compared on a single slide must be dyed
with two different fluorescent dyes to obtain separate measures of expression for each
sample. Effects on expression associated with sample variety are of scientific interest,
but the dyes themselves exhibit effects that can obscure variety effects if experiments
are not designed properly (Kerr and Churchill, 2001a). Various normalization strategies
have been proposed for removing dye effects prior to statistical analysis (Bolstad et al.,
2001; Yang et al., 2002; Smyth and Speed, 2003; Cui et al., 2003). These strategies
successfully reduce global effects common to all genes or to groups of genes with similar
intensity levels, but gene-specific dye effects will remain after normalization (Kerr and
Churchill, 2001b). Thus it is important to account for dye effects in the design and
analysis of two-dye microarray experiments.
The simplest and perhaps most common two-dye microarray experiment involves
comparing the expression of thousands of genes between two varieties (e.g., treated vs.
control, cancerous tissue vs. non-cancerous tissue, mutant vs. wild type, etc.). Dobbin,
Shih, and Simon (2003) discussed experimental design issues for such experiments. In
particular, they identified the most efficient design for identifying changes in gene ex-
pression between two varieties when the number of slides is the limiting factor. The
most efficient design is depicted in Figure 1 B. A commonly used alternative design is
depicted in Figure 1 A. In this figure, each circle represents a separate experimental
unit (in the case of a randomized experiment) or sampling unit (in the case of an ob-
servational study). (Henceforth we will use the more generic term unit to refer to either
type of unit depending on the type of investigation under consideration.) Each circle
is numbered according to its variety. Each arrow in Figure 1 represents a microarray
14
slide upon which RNA from the two units connected by the arrow will be measured.
The direction of the arrow indicates the dye assignment by the following convention:
the arrow points from the unit dyed with dye 1 (e.g., green Cyanine 3) to the unit dyed
with the dye 2 (e.g., red Cyanine 5). This symbolic notation is motivated by the figures
in Kerr and Churchill (2001a). The main difference is that we insist on separate circles
for separate units.
Figure 1 Experimental Designs
The adjectives dye-swap, reverse-dye, fluor-reversal, and dye-balanced have been used
in the microarray literature to refer to designs like A in Figure 1 (Dobbin, 2002; He et
al., 2003; Landgrebe et al., 2006). Both designs in Figure 1 involve direct comparison of
varieties on single slides and measurement of each variety an equal number of times with
each dye. The feature that distinguishes design A from design B is that in design B each
unit is measured only once with only one of the two dyes while in design A each unit
is measured twice, once with each dye. Thus design B is dye-balanced within variety
(DBWV) while design A is dye-balanced within unit (DBWU). Designs that are DBWU
will necessarily be DBWV, but we will treat these descriptors as mutually exclusive by
using DBWV to describe the class of designs are that are dye-balanced within variety
but not dye-balanced within unit.
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This paper provides a detailed comparison of the DBWV and DBWU designs de-
scribed in Figure 1. We focus on analysis of data from such designs, and compare the
performance of the two designs using real and simulated data. Our results support the
conclusions of Dobbin et al.(2003) in that we find the DBWV design to be superior to
the DBWU design when the number of slides is the limiting design factor. There are,
however, situations where the number of units is the limiting design factor, and in such
cases, the DBWU design is clearly preferable to the DBWV design. Thus it is important
to develop appropriate analysis strategies for both designs.
While it is relatively straightforward to specify reasonable mixed linear models for
the DBWV and DBWU designs using the approach described by Wolfinger et al. (2001),
it is less straightforward to determine the best analysis strategy within the mixed linear
model framework. Important issues regarding the determination of denominator degrees
of freedom for tests of interest in mixed linear model analysis of microarray data have
gone unaddressed in the literature. We compare multiple analysis strategies for the
DBWV and DBWU designs and provide recommendations for practitioners that should
lead to good performance when testing for differential expression between two varieties
using either of the designs in Figure 1.
In Section 2, we describe two datasets generated by a single laboratory using the
two competing designs pictured in Figure 1. We present a gene-specific mixed linear
model for each design that should capture the important sources of variation in each
experiment. Different methods of analysis are then described in Section 3. The power
and validity of these methods are examined using simulated data in Section 4. The
methods of analysis determined to be most appropriate are then used to compare the
effectiveness of designs A and B for the analysis of actual data in Section 5.
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2 Gene-Specific Models for Two-Variety Two-Dye Microarray
Experiments
2.1 Example Experiments
Two microarray experiments were conducted to identify genes differentially expressed
between kernels from normal maize and kernels from maize carrying a mutation to the
Opaque2 gene. Corn from the mutant maize plant is nutritionally more valuable than
normal corn because the mutant contains higher levels of the essential amino acids lysine
and tryptophan. Unfortunately the mutant corn has other undesirable properties (e.g.,
softer and more easily damaged kernels and lower yield) that prevent its widespread
use as a food source for humans and livestock. The goal of the study was to identify
genes differentially expressed in the mutant to better understand the molecular basis
of phenotypic differences between the normal and mutant. Such information might
eventually be useful for the development of highly nutritious corn without negative
characteristics.
Experiments using the DBWU and DBWV designs depicted in Figure 1 were used
to compare expression in normal and mutant kernels. For these experiments, each unit
(circle in Figure 1) corresponds to a corn plant from which kernels of corn were sampled
from a single ear. A total of 18 plants were used (three pairs of plants for the DBWU
design and six pairs of plants for the DBWV design). The experiments each used six
microarray slides. As is the case in many microarray experiments, the array work was
completed over the course of multiple days. In this case, two arrays were processed each
day for three days for each design. The dye-reversed slides for a single pair of plants were
processed together on a single day when conducting the the DBWU design. Analogously,
dye-reversed slides were processed together when conducting the DBWV design so that
slides like the first two depicted in Figure 1 would be done on a single day.
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2.2 A Mixed Linear Model for the DBWU Design
We propose the following mixed linear model for the normalized log-scale data for
single gene from the DBWU design:
ydvaub = µ+Dd + Vv + Aa + Uu +Bb + dvaub, (1)
where ydvaub denotes the normalized log-scale expression measure from array a, dye d,
variety v, unit u, and block b; µ denotes a fixed intercept parameter; Dd denotes the
fixed effect of dye d; Vv denotes the fixed effect of variety v; Aa denotes the random
effect of array a; Uu denotes the random effect of unit u; Bb denotes the random effect
of block b; and dvaub denotes the random error associated with the observation from
array a, dye d, variety v, unit u, and block b. All the random terms are assumed to be
independent and normally distributed with with mean 0 and variance σ2A, σ
2
U , σ
2
B, and
σ2 for arrays, units, blocks, and error terms, respectively. To simplify notation, we have
omitted a gene-specific subscript that would indicate that all the parameters are unique
for each gene.
For the maize DBWU experiment described in the previous subsection, d = 1, 2
for the 2 dyes; v = 1, 2 for the normal and mutant genotypes; a = 1, . . . , 6 for the 6
arrays; u = 1, . . . , 6 for the 6 plants; and b = 1, 2, 3 for the three processing days used
to obtain the microarray data. It is natural to treat the effects of arrays as random
because the arrays used in any one experiment are almost always a subset of a larger
population of arrays manufactured together for use in many experiments. Similarly
the effects of units are treated as random because it is usually reasonable to view the
units used in any particular experiment as being like a random sample from a larger
population of units that could have been used in the experiment. Furthermore, it is
desirable to generalize our conclusions concerning variety effects to the larger population
of units. The random block effects in this case correspond to the effects associated with
processing days. Alternatively, these block effects could be considered fixed. We discuss
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the implications of this modeling choice in Section 3.
If we adopt the convention of ordering the response first by blocks, then by arrays,
and then by treatments; the covariance matrix for the DBWU design is block diagonal
with blocks of the form
σ2 + σ2A + σ
2
B + σ
2
U σ
2
A + σ
2
B σ
2
B + σ
2
U σ
2
B
σ2A + σ
2
B σ
2 + σ2A + σ
2
B + σ
2
U σ
2
B σ
2
B + σ
2
U
σ2B + σ
2
U σ
2
B σ
2 + σ2A + σ
2
B + σ
2
U σ
2
A + σ
2
B
σ2B σ
2
B + σ
2
U σ
2
A + σ
2
B σ
2 + σ2A + σ
2
B + σ
2
U

.
(2)
Note that this covariance structure is quite complex for dataset with only 12 observa-
tions.
2.3 A Mixed Linear Model for the DBWV Design
We propose the following mixed linear model for the normalized log-scale data for
single gene from the DBWV design:
ydvaub = µ+Dd + Vv + Aa +Bb + εdvaub, (3)
where εdvaub = Uu+dvaub and all other terms are as defined for the DBWU model in (1).
Again, a gene-specific subscript on all parameters has been omitted to simplify notation.
In contrast to the DBWU design, σ2U and σ
2 cannot be separately estimated with data
from the DBWV design because each unit is measured with only one array. However,
the sum σ2U + σ
2 can be estimated with the DBWV design, and this sum, rather than
individual estimates, is sufficient for inference concerning the variety effects of interest.
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The covariance structure is again block diagonal with blocks given by
σ2A + σ
2
B + σ
2
U + σ
2 σ2A + σ
2
B σ
2
B σ
2
B
σ2A + σ
2
B σ
2
A + σ
2
B + σ
2
U + σ
2 σ2B σ
2
B
σ2B σ
2
B σ
2
A + σ
2
B + σ
2
U + σ
2 σ2A + σ
2
B
σ2B σ
2
B σ
2
A + σ
2
B σ
2
A + σ
2
B + σ
2
U + σ
2

.
(4)
3 Methods of analysis
3.1 Mixed Linear Model Analysis Using SAS
The MIXED procedure in SAS, version 9.1 (SAS Inc., Carey, NC) is perhaps the
most widely used code for mixed linear model analysis. The MIXED procedure uses
flexible and convenient syntax that permits the fitting of general mixed linear models
as described by Littell, et al.; 2006. It is straightforward to specify the mixed linear
models for the DBWU and DBWV designs in MIXED syntax and to fit the models to
thousands of genes in a sequential manner. Example code is provided in the appendix.
When using the MIXED procedure to fit the DBWU and DBWV models, p-values
from F-tests (or, equivalently, t-tests) for variety and dye main effects are automatically
generated. The p-values from the tests for variety main effects can be used to identify
differentially expressed genes. A common strategy is to reject the null hypothesis of no
differential expression for any gene whose p-value falls below a threshold for significance.
Usually the threshold for significance is chosen to obtain approximate control of the false
discovery rate (FDR). Benjamini and Hochberg (1995) and Storey and Tibshirani (2003)
among many others have provided methods for FDR control that can be applied to a
collection of p-values. All of these methods require that a p-value from a test with a
true null hypothesis be uniformly distributed on the interval [0, 1].
Unfortunately, the assumption that p-values will be uniformly distributed under the
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null is in doubt when conducting mixed linear model analysis of DBWU and DBWV
experiments like those described in Section 2.1. When sample sizes are small and covari-
ance structures are complex, the restricted (or residual) maximum likelihood (REML)
estimators for one or more variance components may fall on the boundary of the param-
eter space with non-negligible probability. When this happens, the MIXED procedure
essentially fits a model that excludes all random factors whose variance components
were estimated to be zero. To understand how this can lead to tests whose p-values
are not uniformly distributed under the null, it is necessary to consider SAS options for
determining the denominator degrees of freedom of the reference distribution used to
compute a p-value.
The default SAS method for determining the denominator degrees of freedom is the
containment method. With the containment method, the syntax used to specify the
model determines the denominator degrees of freedom according to rules described in
SAS/STAT (1989). There are some drawbacks to the containment method. First, it is
possible that multiple specifications of the same mixed linear model will lead to different
inference concerning fixed effects of interest. An example is provided in the appendix.
Second, the procedure can result in conservative inference by using substantially fewer
denominator degrees of freedom than appropriate when considering the model ultimately
fit to the data. For example, consider a gene from our DBWU experiment for which the
array, unit, and block variance components are all estimated to be zero when SAS code
for the DBWU model (provided in the appendix) is used for analysis. In this case, the
MIXED procedure will essentially fit a fixed-effects-only model with three free parame-
ters and 12 observations. An analysis based on this model should yield 9 denominator
degrees of freedom for a test of variety main effects. However, the containment method
will use only 2 denominator degrees of freedom when determining the p-value for the
test. This results in a null p-value distribution that is stochastically larger than the
uniform distribution and leads to conservative inference as shown in the simulations of
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Section 4.
The other methods for determining the denominator degrees of freedom for models
like (1) and (3) are the Satterthwaite method (Satterthwaite, 1946) and the Kenward and
Roger method (Kenward and Roger, 1997). For t-tests or F-tests with a single numerator
degree of freedom, the Kenward and Roger method is equivalent to Satterthwaite’s
method. Thus it is sufficient to consider only Satterthwaite’s method here, given that
the test of variety main effects is a single degree of freedom F-test.
Sattherthwaite’s method is typically used when the denominator of an F-statistic
is a linear combination of mean squares with differing expectations. In such instances,
the null distribution of the test statistic will be only approximately F-distributed. The
Satterthwaite method uses the observed mean squares involved in the linear combination
and their degrees of freedom to determine a denominator degrees of freedom value that
can be used to conduct the approximate F-test.
If the Satterthwaite method is selected when fitting models (1) and (3) using the
MIXED procedure, the tests for variety main effects will be identical to those obtained
using the containment method, provided that no variance components are estimated to
be zero. On the other hand, if one or more variance components are estimated to be zero,
the Satterthwaite denominator degrees of freedom will be redetermined for the model
that excludes all random factors with zero variance component estimates. This is in
contrast to the containment method where the denominator degrees of freedom depend
only on the syntax used to specify the initial model. The redetermined Satterthwaite
degrees of freedom are, in many cases, the same as the degrees of freedom that would
have been obtained using either method had the random factors with zero variance com-
ponent estimates been initially excluded from the model. For example, consider again
a gene from our DBWU experiment for which the array, unit, and block variance com-
ponents are all estimated to be zero. When the Satterthwaite method for determining
the denominator degrees of freedom is specified for the fit of the initial model (1), the
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denominator degrees of freedom will be recalculated to be 9 to match the error degrees
of freedom of the fixed-effects-only model that is ultimately fit to the data because of
the zero variance component estimates.
When either model (1) or (3) is fit to data for thousands of genes, the Satterthwaite-
derived denominator degrees of freedom will vary from test to test depending on which
variance components are estimated to be zero. The null distribution of the p-value for
the test of variety main effects that results from this testing procedure is unknown and
unfortunately intractable. We investigate this distribution via simulation in Section 4.
3.2 Analysis by Differences
As an alternative to the mixed linear model analysis described above, the data can
be reduced to differences prior to analysis. Consider first the DBWV design and the
differences formed by subtracting the variety 2 normalized log-scale expression measure
from the variety 1 normalized log-scale expression measure to obtain one difference for
each array. Based on model (3), this will lead to differences of the form
diff1 = (V1 − V2) + (D1 −D2) (1) + δ1
diff2 = (V1 − V2) + (D1 −D2) (-1) + δ2
...
diffn−1 = (V1 − V2) + (D1 −D2) (1) + δn−1
diffn = (V1 − V2) + (D1 −D2) (-1) + δn,
where n is an even integer denoting the number of arrays and δ1, . . . , δn are independent
and identically distributed normal random variables with mean 0 and variance 2(σ2U+σ
2).
Note that V1 − V2 and D1 − D2 are the intercept and slope, respectively, of a simple
linear regression model with response values diff1, . . . , diffn and explanatory values x =
1,−1, . . . , 1,−1. Thus a test of variety effects can easily be obtained via the simple
linear regression t-test or F-test for non-zero intercept. Under the null hypothesis of
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no variety effects, the test statistic will have a central t or F-distribution with n − 2
denominator degrees of freedom, and this test will be exact even if one or more of the
variance components in model (3) are truly zero. Thus, as long as the assumptions of
model (3) hold, the p-value for this variety test will be uniformly distributed on [0, 1].
A similar differencing strategy can be used to analyze data from a DBWU design.
However, the array specific differences are not all independent because each experimental
unit is measured on two arrays. Thus, the differences from a pair of arrays measuring a
pair of experimental units should be averaged prior to analysis to obtain n/2 differences
that are independent and identically normally distributed with mean V1−V2 and variance
2σ2U + σ
2. A one-sample t-test for non-zero mean with n/2 − 1 degrees of freedom can
be used to test for variety effects. As was the case for the DBWV design, this test will
be exact regardless of the true values of the variance components, and the uniformity of
p-values under the null hypothesis is guaranteed whenever model (1) holds.
If no variance components are estimated to be zero with mixed linear model analysis,
then the tests for variety effects will be identical for the difference-based analysis and
both mixed linear model analysis strategies discussed in the previous subsection. How-
ever, when one or more variance components are estimated to be zero, the inferences
of interest regarding variety effects may differ drastically between the difference-based
approach and mixed linear model analysis. We investigate the relative performances of
these methods in the next section.
4 Simulations and Results
4.1 Data simulation
Simulations were ran to compare the discussed methods of analysis for both the
DBWU and the DBWV designs and then to use the best method of analysis to compare
the powers of the designs. Nine scenarios were simulated as though they consisted of a
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10,000 gene experiment performed twice using both designs. Each scenario was created
using twelve observations per gene, or six arrays, resulting in 120,000 observations per
data set, or experiment. We chose to study six-array experiments because two-treatment
experiments of this size are common in practice. Experiments following both the DBWU
and the DBWV designs were created using Models 1 and 3 for each simulation setting. To
ensure realistic values in creating the data, variance component estimates were obtained
from the corn experiment discussed previously. The nine scenarios were created using
various combinations of the 25th, 50th, and 75th percentiles of the variance component
estimates from the analysis. These combinations can be seen in Table 4.1. Because
one of the main interests was in the effect of variance components being estimated to be
zero, simulation settings were used which would promote this to occur. For one scenario,
the block variance component was actually set to be zero. Simulation setting 2 shown
in Table 4.1 was created using variance component settings to minimize zero variance
component estimates for the sake of comparison with the other settings in which variance
components would be expected to be estimated zero frequently. Each of the 10,000 genes
within one scenario, or simulation setting, had the same variance components. To make
the DBWU and DBWV values in the same scenario, the exact same values were used
for the block, array, variety, dye, and measurement error effects for every observation.
This could not be done for the unit effect since the DBWU design uses half the number
of units that the DBWV design uses. However, the six unit values used in creating the
DBWU data were included in the twelve unit values used in creating the DBWV data.
The high level of homogeneity was used to increase the accuracy of the comparison of
each design’s power.
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Random
Factor Dataset Number
1 2 3 4 5 6 7 8 9
Error 50 25 75 75 75 75 75 75 75
Unit 50 75 25 50 50 25 25 50 25
Array 50 75 50 25 50 25 50 25 25
Block 50 75 50 50 25 50 25 25 0
Table 1 Simulation settings in quantiles of variance component estimates
from corn experiment.
4.2 Method of Analysis Comparison
4.2.1 Analysis of DBWU data
The first time each simulation setting was analyzed, no variety differences were in-
cluded. Each simulation setting was analyzed by mixed model analysis using both the
containment and the Satterthwaite methods of estimating the denominator degrees of
freedom. The model used for this analysis is shown in Equation 1. Analysis was also
performed on the differences as described in Section 3.2. Due to the omission of vari-
ety effects, the resulting p-values from each analysis would be expected to follow the
uniform distribution [0,1]. This had to be true for the analysis of differences because
the data was created under the model assumptions. Since there was no difference in
variety means included, the null hypothesis was true causing the t statistics to follow
the central t distribution resulting in p-values that follow the uniform distribution[0,1].
Mixed model analysis using the containment method for estimating the denominator de-
grees of freedom resulted in a conservative p-value distribution for every scenario except
number 2 where variance components were rarely estimated to be zero. Mixed model
analysis with the Satterhwaite estimate also showed conservative results when the unit
variance component was very small relative to the measurement error. Figure 2 displays
the p-values for each analysis method resulting from simulation setting 6. Each p-value
distribution is also shown in Figure 3 as histograms to aid in showing how conservative
26
the p-values obtained by mixed model analysis are.
Figure 2 P-value distributions attained for scenario 6 using each method of
analysis considered for experiments following the DBWU design.
For data from a microarray experiment following the DBWU design, analysis of the
differences would be recommended so that the p-value distribution can be assumed to
follow the uniform distribution when the null hypothesis is true and the assumptions are
met. This enables accurate estimates of the false discovery rate. If using the mixed model
analysis, conservative results could occur under certain variance components regardless
of which method is used in estimating the denominator degrees of freedom.
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Figure 3 P-value histogram shown for each method of analysis used for
scenario 6 along with the uniform distribution.
4.2.2 Analysis of DBWV data
For the simulation settings following the DBWV design, mixed model analysis was
performed using the model shown in Equation 3. Both methods of estimating the denom-
inator degrees of freedom were once again used. Analysis of differences was performed
using the method in Section 3.2 for the DBWV design. The p-value distributions for the
DBWV design were much different than those obtained for the DBWU design. Here, the
p-values obtained through mixed model analysis using either the Satterthwaite or con-
tainment methods of calculating the denominator degrees of freedom resulted in p-values
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with a liberal bias, or lower than expected values. This would cause more hypothesis to
be rejected than is appropriate, increasing the true false discovery rate. The more often
variance components were estimated to be zero, the more liberal the p-value distribu-
tions became. Since the simulated data were from a normal distribution and each gene
was independent, the test statistic for a variety effect when using analysis of differences
did follow the central t-distribution causing the p-values to follow the uniform distribu-
tion. The p-value distribution of each analysis method for scenario 9 is shown in Figure
4. Since the denominator degrees of freedom can only be increased when using the Sat-
terthwaite estimate and a variance component is estimated to be zero, this method only
increases the liberal bias.
Figure 4 P-value distributions attained for scenario 9 using each method of
analysis considered for experiments following the DBWV design.
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Once again the analysis of differences is recommended in order to obtain dependable
results. The p-value distribution when using mixed model analysis can have a liberal
bias making p-values and false discovery rates difficult to trust.
4.3 Design Comparison
Both the DBWU and the DBWV experimental designs are for comparing only two va-
rieties. Therefore the only comparison of interest is for an expression difference between
the genotype varieties in the corn experiment. The standard error for comparing the
differences between the genotypes for the corn experiment when following the DBWU
design is
√
2
σ2U
3
+ σ
2
3
. σ2U represents the variability among the units while σ
2 is the
measurement error. The standard error for the differences in genotypes in the corn ex-
periment using the DBWV design is
√
σ2U+σ
2
3
. With the DBWU design, there is twice as
much unit variability in the standard errors for the differences in the genotypes because
this design uses half the number of units to estimate the unit variability.
It has already been shown that the DBWU design outperforms the DBWV design
when comparing their variances for variety differences. The amount is dependent upon
the the relationship between unit variability and measurement error. To measure the
benefit, the two designs were compared using real data. The designs were compared
by the resulting p-values from analysis of differences to maximize the accuracy of the
comparison. Figure 5 displays the additional power achieved when using using the
DBWV design over the DBWU design in the corn experiment described previously.
Using the DBWU design resulted in 376 genes with p-values less than .01 compared
to 1655 genes for the DBWV design. Using a cutoff of 5%, yields 1563 genes with the
DBWU design and 3357 with the DBWV design, more than doubling the number of
genes detected as differentially expressed.
There are over 5 times the number of genes with p-values less than .01 when using the
DBWV versus the DBWU design. There are over twice as many when using a p-value
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of .05 as a rejection value.
Figure 5 Design comparison from the transgenic corn experiment.
As an alternative, the variance estimates for the variety differences were also com-
pared for the two designs. This was done by measuring the relative efficiency by cal-
culating V̂arDBWU( ̂V1 − V2)/V̂arDBWV ( ̂V1 − V2) for each of the 11,978 genes tested in
the corn experiment. Quantiles of the measurements are shown in Table 2. The rel-
ative efficiencies were less than one only about 38% of the time indicating that the
variance estimate from the DBWU design was only smaller than that of the DBWV
design slightly more than one third of the time. The increased accuracy of the va-
riety differences is an additional strength of the DBWV design. The DBWV design
also has added denominator degrees of freedom received in the F-test for variety dif-
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ferences. Because this will also add to the power of the tests, a relative efficiency that
will account for this difference in degrees of freedom was also calculated. The Fisher
relative efficiency (Kuehl, 2000) is calculated by multiplying the relative efficiency by
(1 + dfnum) (3 + dfden) / (3 + dfnum) (1 + dfden). Using the Fisher relative efficiency in-
creased the benefit shown in using the DBWV design. Both of these measurements
indicate the additional power received using the DBWV design.
Min 10% 25% 50% 75% 90% Max
Rel. Eff. .000038 .1376 .5119 1.643 5.054 14.991 7518.8
Fisher RE .000046 .1686 .6094 1.956 6.016 17.846 8950.1
Table 2 Quantiles of the relative efficiencies.
The designs can also be compared by their power to find differences of varying magni-
tude. Since analyzing the differences has been shown to be the better method of analysis,
the distribution of the test statistic is known as long as the distributional assumptions
are met. When using the DBWU design with six arrays as in the simulated scenarios,
the F-statistic for the test of variety differences will follow the F-distribution with one
degree of freedom in the numerator and two degrees of freedom in the denominator and
a non-centrality parameter of
(V1 − V2)2(
2σ2U+σ
2
3
)
where Vi is the mean of variety i, σ
2
U is the unit variability, and σ
2 is the measurement
error. When the null hypothesis of equal variety means is true, the non-centrality pa-
rameter will equal zero and the F-statistic will follow the central F distribution. When
under the same conditions and using the DBWV design, the F-statistic for the test of
variety differences will follow the F-distribution with one degree of freedom in the nu-
merator and four degrees of freedom in the denominator and a non-centrality parameter
of
(V1 − V2)2(
σ2U+σ
2
3
) .
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Using these known distributions, the power of both designs are compared in Figure
6 using a p-value of .05 as the criterion for rejecting the null hypothesis. The x-axis
displays absolute values of variety mean differences and the y-axis shows the power to
find a difference of that degree. The design powers are compared using quartiles of the
variance components from the corn experiment as values for σ2U and σ
2 which are shown
on the title of each plot. Often in microarray experiments, researchers wish to find
expression differences in terms of fold changes. Because the variance component values
are from a natural log scale the differences would have to be exponentiated to determine
the fold change. To show the power of the two designs relative to specific fold changes,
a blue line was drawn at a two-fold variety mean difference, an orange line at a five-fold
mean difference, and a maroon line at a ten-fold mean difference. These figures show a
definite increase in power when using the DBWV design over the DBWU design. This
benefit is increased as the unit variability increases relative to the measurement error.
This would be expected since the DBWV has twice as many units and the DBWU design.
Also, under the conditions of the corn experiment, neither design had much power in
detecting a two-fold change but the DBWV design shows great power in detecting a
five-fold change under any of the variance component values shown.
5 Conclusions
There are two main points to be made: First, the DBWV design is the best to use
when the number of slides is the constraint in designing a microarray experiment for
two treatments. Regardless of the the method of analysis or the values of the random
effect parameters used, the DBWV design will lead to more powerful tests than those
obtained when using the DBWU design. This is shown using both real and simulated
data. However, this does not mean that the DBWU design should not be used. There
can be times where the number of units is the constraining factor and repeating the
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measures using a DBWU design would add to the accuracy and lower the variability. A
benefit of the DBWU design is that a researcher can separate the biological variability,
or the variability between the units, from the technical variability coming from the
laboratory. The variability between measurements coming from the same unit estimates
the technical variability. A combination of techincal and biological variability can be
estimated by comparing differences between units from the same variety. These can be
separated using the estimate of technical variability. This could be valuable information
if deciding on different possible laboratories or technical procedures to use.
The second main point is that regardless of which design is used, analyzing the dif-
ferences should be preferred when the dataset is of limited size. For the DBWV design,
analyzing differences can eliminate liberal bias. If using the DBWU design, analysis of
differences can eliminate conservative bias. Regardless of the design, analyzing the differ-
ences will eliminate additional concerns induced when at least one variance component
is estimated to be zero.
One detail to note is that both the nobound and type3 methods on PROC MIXED
were considered as possible solutions. The nobound option allows negative estimates of
random effect parameters which prevents any of the parameters from being removed from
the model. Instead of a random effect being removed from the model, it is estimated
to be zero or less when using the nobound option. However, when using this method,
the REML algorithmic procedure failed to converge for some of the simulated genes.
Because of this problem, this method was not considered as a solution to the concerns
found when using mixed model analysis. Another option was the type3 method. This
procedure obtains a method of moments estimator of the variance components by using
the Type III expected mean squares and the Type III mean squares values. This method
also allows negative estimates of covariance parameters. This method had to be removed
from consideration because confounding between the block and array effects created
singularity conditions by which the expected mean squares could not be calculated.
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Microarray Experimental Design Selection Accounting for
Mixed Model Variability
Justin C. Recknor and Dan Nettleton
Abstract
Many microarray experimental designs, when using two-dye spotted arrays, require
more than one variance component in the model. In the past, array differences have been
used to eliminate this difficulty when possible. However, loss of power is shown to occur
when using this data adjustment when compared to using the full data in mixed model
analysis. Mixed model experimental design comparison is proposed to allow design
selection pertaining to the more powerful mixed model analysis. Optimal designs are
shown to rely heavily upon the distribution of the variance components. Due to this
factor, prior knowledge of parameter sets are shown to be a valuable asset. Designs are
initially compared with a constraint upon the number of arrays possible to use in the
experiment. Alternatively, experiments are often constrained by an expenditure limit.
A design selection is compared which shows that selecting the optimal design can rely
upon the cost ratios of objects required in the experiment as well as the distribution of
the variance components.
1 Introduction
Two-color microarray experiments are a valuable resource in biological research to-
day. These experiments enable one to measure the relative level of expression of thou-
39
sands of different genes in one experimental unit at any specific time. There are different
types of microarray experiments that are performed but this paper is only concerned with
two-dye spotted microarrays. These microarray experiments begin by taking samples of
mRNA from the experimental unit. (The units could also be called observational units
when dealing with an observational study, but they will be referred to as experimental
units in this paper.) Next, the mRNA is converted to cDNA and a dye is applied to the
sample. Both a red and a green dye are usually used. Applying the different colored
dyes to samples enables two different samples to be placed on the same array. Sam-
ples are referred to within this paper as mRNA which is removed from an experimental
unit, has a dye applied, and measured upon a slide. This term is not exchangeable
with experimental unit because there can be multiple samples measured from one unit.
Slides are produced specifically for the organism that is being studied. Each slide, or
array, contains thousands of different spots, each of which has cDNA sequences that are
complementary to a proportion of the cDNA sequence of a specific gene. The cDNA
from one gene will bind to its complementary sequence at a specific location. Then,
lasers excite the samples which enables measurements of the relative quantity of cDNA
that is bound to each spot. This measurement is used to estimate the mRNA present
within the experimental units that are sampled at that time. Due to the dye which
was applied to the samples, two different experimental units can be measured together
on a slide. Microarrays enable researchers to learn valuable information about cell life
and gene expression under many different conditions. Along with this expanding area
of research comes many very large data sets and new problems in how to handle and
analyze this data. New statistical techniques are being developed constantly to improve
the performance of such experiments.
In the early days of microarray experiments, much of the research being performed
was on how to normalize and analyze the data. For the raw data, the effects are assumed
to be on a multiplicative scale and a log transformation is used to convert this to an
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additive scale for modeling and analysis (Kerr et al., 2000). Variety means are usually
compared by ratios, or fold changes, because of the multiplicative scale. Along with the
log transformation, normalization of the data is necessary because one dye will get higher
measurements than the other when the same amount of cDNA is present. This problem
is viewed as technical variability, or a bias introduced through laboratory procedures.
However, this is not considered biological variability and data are commonly adjusted
prior to being analyzed to remove this hindrance. The dye bias has been shown to
be reliant upon the signal intensity which makes it more difficult to handle. A large
number of methods have been proposed to remove this, many of which use some form
of LOESS regression (Smyth and Speed, 2003; Yang et al., 2002). These processes are
meant to remove global dye effects, or non-gene-specific dye biases. Research has shown
an interaction between gene and dye to also exist (Kerr, 2003). Since this is gene specific,
a dye effect is usually included in the model when doing gene-by-gene analysis to avoid
additional variability or biased results.
Kerr and Churchill (2001b) first proposed classical ANOVA as a method of analysis
for microarray experiments. This was meant to be performed, on the log transformed
data, simultaneously for all genes with global and gene specific effects. An alternative
method was proposed which eliminated the normalization step by modeling for both the
global and gene specific effects (Wolfinger et al., 2001). This was done by first modeling
the entire data set by global effects, or non-gene specific effects such as global dye bias.
The residuals were then analyzed by gene to test for the gene specific effects. Experi-
mental design considerations increased as the research into microarrays progressed.
Experimental design is an important part of microarray experiments. With the
high cost of arrays, and possibly experimental units, the number of experimental units,
samples, and arrays can be very limited in many experiments. Thus, using the best
design to maximize the power is imperative to ensure success. Much literature has
been published discussing different aspects of microarray experimental design. Early
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papers covered different levels of variability and possible dye bias to consider when
designing experiments (Kerr and Churchill, 2001a). Other papers proposed designs that
were superior to the reference design (Dobbin and Simon, 2002; Townsend, 2003). The
reference design received its name because every sample for a variety being studied in
an experiment was paired on an array with a reference. The reference itself, is a variety,
or treatment, that is not being studied but instead used as a standard. Often the
reference would be many different samples such as all the varieties pooled together. The
differences between each variety and the reference from the same array were then used in
the analysis. This experimental design was frequently used in microarray experiments,
especially when there were a large number of treatments being compared. Later articles
have been concerned with everything from necessary biological sample sizes (Yang et al.,
2003) to comparisons of specific designs (Dobbin et al., 2003).
Two-dye microarray experiments should always have an array effect in the model
(Kerr and Churchill, 2001b) and arrays are usually treated as random effects. The
arrays are viewed in this manner because an experiment is performed by purchasing
arrays containing sequences specific to the organism of interest. Usually, many other
experiments are being performed on other identical arrays. This enables the arrays to be
viewed as a random sample from a large population. Treating arrays as random forces
the analysis of all spotted microarray experiments into having to estimate more than one
variance component. Multiple researchers (Glonek and Solomon, 2004; Yang and Speed,
2002; Kerr and Churchill, 2001b) have proposed transforming the microarray data after
normalization by calculating the differences between measurements from the same array.
For example, all the red dye measurements would have the green dye measurements for
the same gene subtracted from them. These differences remove the array effect reducing
the number of variance components in the model to one. In order to use this method,
the parameters would need to be be calculated for each array difference and model the
reduced data accordingly. Since the model for the experiment now contains only one
42
variance component, it can be written in matrix form as Y = XDβ + . Y indicates
a vector of responses, or differences, while XD indicates the experimental design after
taking the differences and β is a vector of unknown parameters. The vector  indicates
random errors which are assumed to be independently normally distributed with mean
0 and variance σ2. Under these assumptions, E(Y ) = XDβ with a variance of Inxnσ
2.
X ′DXD will be assumed to be of full rank in this paper, enabling β to be estimated using
(X ′DXD)
−1X ′DY . If XD was not full rank then a generalized inverse of X
′
DXD would be
used instead. The resulting variance of the estimate of the unknown parameters, βˆ, is
σ2(X ′DXD)
−1.
Glonek and Solomon (2004) compared many experimental designs by values propor-
tional to the variances of contrasts of interest. Estimable hypothesis tests can be written
in the form H0 = K
′β and estimated by K ′βˆ which has a variance of K ′(X ′DXD)
−1Kσ2.
Since the σ2 is the measurement error, it will retain the same value regardless of the
experimental design used. This fact allows designs to be compared simply upon the
values on the diagonal of the K ′(X ′DXD)
−1K matrix by dividing the contrast variance
matrix of all designs considered by σ2. When computationally practical, Glonek and
Solomon would compare all possible designs for a specific number of varieties and ar-
rays. For “all possible designs”, some constraints need to be mentioned. These are all
of the designs for which the model, before calculating array differences, contains only
two variance components, array and measurement error. This eliminates a large number
of designs from consideration, for example, all designs which have experimental units
being measured more than once. One design could dominate another one if the cor-
responding variances for the contrasts were always less than, or equal to, the contrast
variances of the other design. However, for at least one of these variance comparisons,
the variance of the dominant design would have to be strictly less than that of the
other. If a design could not be dominated by any other design, then it was declared
admissible. Using this method, only the admissible designs would be considered for any
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experiment. Earlier, Kerr and Churchill (2001b) had proposed using the same reduction
of the data but using the A-optimality criterion over all pairwise treatment differences
in choosing an experimental design. A-optimality requires averaging the variances for
all tests of interest and using the design which minimizes this value. Yang and Speed
(2002) proposed a similar design selection procedure also using the transformed data.
They proposed calculating the variances for some m estimable contrasts ( K ′1β...K
′
mβ ).
Then, for the matrix of estimable contrasts of interest, called C, for which the variance
is written as V σ2 = C ′(X ′DXD)
−1Cσ2, the design to use is selected by minimizing the
largest eigenvalue of V.
2 Benefit of Using Mixed Model Analysis
When allowing for random effects, the linear model can be written in matrix form
as Y = Xβ + Zγ + . The β represents the unknown fixed effects parameters while
γ designates the random effects. The X matrix indicates the experimental design for
the fixed effects while the Z matrix, usually a dummy matrix, indicates the design of
the random effects. Commonly, it is assumed that  ∼ N(0,R) and γ ∼ N(0,G) with
Cov(,γ)=0. Estimable hypothesis tests of fixed effects are still calculated using K ′βˆ,
now with a variance of K ′(X ′V −1X)−1K where V = ZGZ ′ + R. The matrix X ′V −1X
will be assumed to be of full rank throughout this paper allowing the inverse to be
calculated. If this condition is not true, the generalized inverse would be necessary to
use instead.
A problem introduced when reducting the data to differences of the data instead
of mixed model analysis is the loss of inter-block information. Since each array can
measure two varieties, and is treated as a random effect, it can be viewed as a blocking
factor. Since the array effect should always be included in the model, all spotted two-
dye microarray experiments automatically follow a block design with a block size of
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Figure 1 Designs A-C are from Glonek and Solomon(2004). Each arrow
indicates an array in which the arrow points from the sample dyed
green to the sample dyed red. Each corner indicates a variety
level, not an experimental unit, so no experimental unit is sampled
more than once. α and β indicate variety main effects with αβ
indicating interaction
two. When there are more than two varieties being studied, the experiment follows an
incomplete block design because every treatment cannot be contained within one block
simultaneously. Treating arrays as a random effect allows information to be shared
about variety differences between blocks, or inter-block. The inter-block information is
beneficial when dealing with incomplete block designs. Using the inter-block information
can reduce the variance of a test, increasing the power. For example, assume Design C
from Glonek and Solomon (2004), which is shown in Figure 1, was used in performing
a microarray experiment. In this figure, each circle represents an experimental unit and
each arrow represents an array. The direction of the arrow indicates the dye assignment
by the following convention: the arrow points from the sample dyed green to the sample
dyed red. The expected variances of estimators of the parameters of interest (α, β,
and αβ) are shown in Table 1 for both mixed model and array differences methods of
analysis.
These equations assume σ2A symbolizes the array variability while σ
2 is the measurement
error. The expected variance for the test for interaction (αβ) is the same for both meth-
ods. However, the expected variances for the main effects (α and β) differ substantially
depending upon the method of analysis used. By an algebraic adjustment to the vari-
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Parameter
Method
α β αβ
Differences 3σ
2
4
3σ2
4
σ2
Mixed Model
σ2(3σ2A+2σ
2)
4(σ2+σ2A)
σ2(3σ2A+2σ
2)
4(σ2+σ2A)
σ2
Table 1 Expected variances for parameters of interest for both methods of
analysis.
ance equations, a lesser variance estimate is evident for mixed model analysis. This is
because
σ2(3σ2A + 2σ
2)
4(σ2 + σ2A)
=
3σ2
4
(
σ2A +
2
3
σ2
σ2A + σ
2
)
<
3σ2
4
since
σ2A +
2
3
σ2
σ2A + σ
2
< 1.
The inequality is strict because σ2 > 0.
The extent of a difference the change in variance makes is shown through simulation.
Data sets were created using variance component sets from an actual experiment that
followed a related design. Mixed model analysis led to a definite increase in power in the
tests for main effects. This can be seen in the Receiver Operating Characteristic (ROC)
curve for α shown in Figure 2. The data analyzed was simulated by four repetitions
of Design C from Figure 1. An effect, which followed a log-normal distribution, was
included for α, β, and αβ in 75% of the genes created. This plot displays the percentage
of false conclusions (null hypotheses incorrectly rejected) necessary to find a specific
percentage of the the true differences (null hypotheses correctly rejected). For example,
if it was desired to find 40% of the different population means for α then it would require
finding approximately 19% of the means that are not different in this data set when using
mixed model analysis. If the differences method of analysis was used instead, then it
would require finding approximately 22% of the means that are not actually different
in order to find 40% of the different means as desired. The ROC curve for β is very
similar. These plots show the benefit in using mixed model analysis for the main effects
with this experimental design. Both methods of analysis led to essentially the same
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results in testing for interaction which is no surprise since both methods have the same
expected variances for this paramter. Also, the distribution of the p-values when the
null hypothesis was true appeared to follow the uniform distribution for both methods
of analysis.
Figure 2 Receiver Operating Characteristic (ROC) curve for α resulting
from the simulated data.
3 Mixed Model design comparisons
3.1 Equation Comparisons
If mixed model analysis is going to be used to increase the power of the experiment,
the process of design selection should take that into consideration. One method to use
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in design selection would be to derive the equations for the variances of the parameters
of interest for each design. These equations could then be used to compare the designs
of interest. Let H0 : K
′β = 0 indicate estimable hypotheses of interest pertaining to the
fixed effects in the model. Then designs would be compared using the equations from
the diagonal of the K ′(X ′V −1X)−1K matrix. As an example, Designs A and B, shown
in Figure 1, are compared by their interaction variances. The equations were calculated
and are shown in Equation 1. The array variability is shown by σ2A while σ
2 represents
the residual variance or measurement error. As can be seen here, although it is possible
derive the equations, it can be time consuming and their complexity leaves the design
comparison difficult to manage.
Design A =
(22σ2A + 15σ
2)(2σ2A + σ
2)σ2
30σ4A + 41σ
2
Aσ
4 + 14σ2
Design B = 16
(σ2A + σ
2)σ2
13σ2A + 14σ
4
(1)
3.2 Comparing Designs on the Basis of Pilot Data
To avoid the complexity issues of the equations, designs can also be compared using
values of the standard errors of tests of interest without actually calculating the variance
equations. At least one set of values of the variance components is necessary to use this
method. Following the model described in Section 2, the X and Z matrices need to be
created according to the design to study. The R and G matrices will need to be created
according to the design while using the predefined values of the variance components.
Using these matrices along with estimable contrast values for K ′, the variance for each
test of interest can be retrieved from the diagonals of K ′(X ′V −1X)−1K. The criteria
used in comparing the designs would depend upon the goals of the experiment. For
example, say an experiment was to have a two factorial treatment structure with mod-
eling Treatments A, B, and their interaction. Assume the interaction was the primary
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concern with the effects of Treatment A as the second of interest, and little interest in
the effect of Treatment B. If there were two designs to be compared, then a ratio of their
interaction variances would be calculated for each set of variance component values. If
multiple sets of variance components were used, a graphical representation of the ratios
could reveal valuable information about the circumstances where one design would be
favored over the other. So to compare two experimental designs, when the test of inter-
est can be written as H0 : K
′β = 0, the ratio of V arDes1(K ′βˆ)/V arDes2(K ′βˆ) would be
calculated across differing values of variance components. Varying processes could then
be used to select a design with these values. One choice could be that if the median ratio
> 1 then Design 2 would be chosen, otherwise Design 1 would be used. If there were
more than two designs being compared, then a rank test could be used. The variances
of the test of interest would be ranked by design for every set of variance component
values. The design with the minimum mean rank would then be chosen. These are just
some options because the method of comparison to use would depend upon the goals of
the experiment. If there were multiple effects of equal interest, than a comparison using
the A-optimality criterion could be used.
Estimates of the variance components are required to use this method. They could
be obtained in two different manners, selection of which depends on the prior knowledge
of the circumstances. If there was little known about the expected variability of the
data, then the designs could be compared over a range of parameter values that seemed
reasonable. If a similar experiment had been ran previously, then the data set of variance
components from that experiment could be used to compare designs under consideration.
This method would give a more accurate portrayal of the parameter space by using
a more accurate range of values and accounting for possible correlation amongst the
variance components. Code was written in R to compare designs using both types of
variance component values.
Simply comparing variance estimates simplifies the analysis, over using variance equa-
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tions, and has results which are easy to understand. This method was performed in R
by creating the corresponding matrices and computing K ′(X ′V −1X)−1K. The variance
component values used were obtained in both manners described previously, using a
range of reasonable values and by use a variance component estimates from a related
experiment.
3.3 Benefits in Using Mixed Model Design Comparisons
The methods discussed previously require transformation of the data with the re-
sulting observations all being independent to be able to compare experimental designs.
This criterion does allow consideration of many designs but also eliminates many other
designs from the list of possible alternatives. For example, a design commonly used in
microarray experiments is the loop design, for which a three treatment example is shown
in Design A of Figure 7. In this design, each experimental unit is measured twice by
samples on different arrays. Due to the repeated measures, if the differences between
measurements on an array were calculated, there would still be a dependence among
these values. This can be seen in looking at the first loop of this design letting D be
the dye effect, V the variety effect, A the array effect, U the unit (experimental unit)
effect, and  the measurement error. Since array, unit, and  are all random effects, each
would be assumed distributed normal with mean 0, and variances σ2A, σ
2
U , and σ
2. An
additional assumption of independence between A, U , and  would also be made. The
model for each observation would be
yijkl = µ+ Ai +Dj + Vk + Ul + ijkl
with i, k and l having values 1-3 and j being either 1 or 2. The array differences would
have the form
yi1kl − yi2k′l′ = D1 −D2 + Vk − Vk′ + Ul − Ul′ + i1kl − i2k′l′ .
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such that
cov(y1111 − y1222, y2122 − y2233) =
cov(D1−D2+V1−V2+U1−U2+1111−1222, D1−D2+V2−V3+U2−U3+2122−2233) =
cov(−U2, U2) = −σ2U = cov(y1111− y1222, y3133− y3211) = cov(y3133− y3211, y2122− y2233)
This dependence between differences within a loop would eliminate this design from con-
sideration by the previously discussed methods although the loop design is commonly
used in microarray experiments. There are many other designs that should be considered
in design comparisons that cannot correctly be handled with a single variance compo-
nent. For many of these designs, mixed model analysis must be used because the data
cannot be transformed to eliminate these additional random effects. Comparing designs
that allow for multiple variance components permits the consideration of more designs
and allows use of the inter-block information in comparing designs.
4 Examples
4.1 Mixed Model Design Selection Versus Array Differences
Selection of experimental designs considering mixed models increases the complexity
of the design comparisons. Choosing the “best” experimental design design can now
depend upon what region of the parameter space the variance components are within.
Although the process may be more difficult, designs can be chosen which fail when using
the array differences methods. Both of these conditions are shown in comparing designs
A and B shown in Figure 1 that were used by Glonek and Solomon (2004). The designs
being compared are for an experiment with a two factorial treatment structure, and 8
arrays to use. The model utilized in analysis is
y = µ+ α+ β + (αβ) + 
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Figure 3 Variance comparison of the interaction parameter (αβ) for designs
A and B. The values being shown are of the variance for Design
A divided by the variance for Design B.
where α and β are the main effect of each treatment and (αβ) is their interaction. When
using the method proposed by Glonek and Solomon (2004), Design A is dominated by
Design B. This means that the variances of Design B, for every parameter of interest, α, β
and (αβ), are less than or equal to those of Design A. Thus, regardless of what parameter
is of main concern for a study, Design B would be the design to use. However, when
the arrays are treated as random the same cannot be said. The optimal design depends
upon the values of the array and measurement error variance components and this is
displayed in Figure 3. The red colored regions are where Design A would have a smaller
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variance in testing for interaction and would be preferred. The blue and green regions
are the opposite, where Design B would be selected. The range of the parameter values
used were obtained from an actual experiment to ensure a realistic comparison. When
the size of the array parameter is small relative to that of the measurement error, Design
A would actually be better to use for estimating the interaction between the treatments.
This may not happen as frequently as the converse, but it definitely shows that there
can be conditions where Design A would be preferred to Design B.
4.2 Comparison of Designs Which Cannot Be Considered Using Array
Differences
Although many designs can be compared using the array differences methods, there
are many others which cannot although they can be compared using the mixed models
approach. As an example, two designs that require repeated measures were compared
by their variances. The two designs are possibilities for use when an experiment has
a 2 by 2 treatment structure, 12 arrays, and 12 experimental units. These designs are
shown in Figure 4 with arrows showing arrays and circles indicating experimental units
as described earlier. Design A is similar to a design examined by Glonek and Solomon
(2004). In that case, there were half the number of arrays being used so only one array
connected each circle but the dyes were still balanced for each treatment. Under Glonek
and Solomon’s conditions, and using their (X ′X)−1 method of comparison, the design
similar to A was shown to be admissible; i.e., no other design could dominate it. Design
A was considered due to its similarity to their design but having the arrays repeated with
the dyes reversed. Design B is 3 loop designs combined but with the array directions
reversing between each loop. Just by looking at the designs, it might appear that Design
A would be better for estimating β since there are four arrays directly estimating that
parameter while there are only three for Design B although only two experimental units
were used for this with Design A while three were used for Design B. Directly estimating
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a parameter means that the expected value of the difference between the measurements
on an array equals, aside from a dye effect, that parameter. The direction of subtraction,
red dye - green dye, can be reversed to prevent expected values of the negative of the
parameter. The contrary is true for α, with 3 arrays directly estimating this parameter
in Design B and 2 in Design A.
Figure 4 Dye balanced microarray experimental designs compared for es-
timation of α, β, and αβ. The designs are compared using both
actual variance estimates and parameter space estimates.
Data from a previous experiment was used to approximate the range of each variance
component’s values. In that experiment, the experimental unit variance component
was estimated to be between .001 and .243. The array variance was estimated to be
within .11 and .34, while the measurement error variance was found to typically fall
between .09 and .23. Approximately 60000 combinations of parameter values within
these ranges were generated. They were obtained by using every value between the
upper and lower estimate of each variance component by increments of .005. Each value
of each variance component was grouped with every possible combination of the values
of the other two variance components. When using this method, Design B always had
a lower standard error for estimating α than Design A. Also, the standard error for
estimating the interaction was always the same. When estimating β Design A had the
lowest standard error approximately 97% of the time. In the cases where Design B did
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better, the unit effect was large while the measurement error was small relative to other
parameter values. The array variability parameter values did not appear to change this
relationship. This can be seen in Figure 5 which is a 3 dimensional plot of a subsample
of the data.
Figure 5 Simulated data design comparison. Blue pyramids represent the
locations where Design B had a lower standard error for estimating
beta. Red stars indicate the locations where Design A had a lower
standard error.
The data set used to obtain estimates of the variance components yielded 9000 point
estimates in three-dimensional space. When these variance component estimates were
used, Design A and B always had the same standard errors when estimating the in-
teraction. Design B also always had a lower standard error when estimating α. For
estimating β, Design A now had the lower standard error only about 60% of the time.
A random subsample of the data is shown in the 3 dimensional plot in Figure 6. When
the actual data is used, it can be seen that the size of the unit variability is frequently
large relative to that of the measurement error. Consequently, Design B tests as a better
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design for estimating β more often, but the standard errors are similar the majority of
the time. If there was equal interest in estimating both α and β and the variance com-
ponents similar to those estimated from the previous experiment could be expected then
Design B would be the logical choice of the two. The benefit in having prior estimates of
variance components is apparent in this example. This is not surprising since the better
design is dependent upon the correlation of the variance components.
Figure 6 Real data design comparison. Blue pyramids represent the loca-
tions where Design B had a lower standard error for estimating
beta. Red stars indicate the locations where Design A had a lower
standard error.
5 Design Comparisons Accounting for Cost
In the examples until this point, the only constraint upon an experiment is the
number of slides, or arrays, that are available to use. However, an experiment could
easily be constrained by an expenditure limit. Under these conditions, the optimal
design to use could depend upon how much the experimental units cost relative to the
cost of the arrays. For example, if a three treatment experiment was being proposed
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on a cost constraint basis, three designs that could be considered are shown in Figure
7. Each circle represents an experimental unit and each arrow represents an array, as
described previously. Each square represents a possible blocking effect. Blocking effects
can be introduced to experiments through a variety of reasons. Blocking effects can be
included in designing the experiment, as happens commonly in plant experiments where
different fields used in the experiment could be viewed as blocking effects. Blocking
effects could also come about during the laboratory work. For example, there are often
constraints on the number of slides possible to process in a day’s time. Slides hybridized
on the same day would have additional correlation, creating the need for a block effect
in the model.
Figure 7 Dye balanced microarray experimental designs considered for a
three treatment experiment. Each circle represents an experimen-
tal unit and each arrow represents an array with the dye assign-
ment for each array determined by the arrow direction. Squares
indicate possible blocks.
Design A is commonly called the loop design and is the only one considered in which
an experimental unit is measured more than once. A benefit of this design is allowing for
unit variability to be estimated by preventing confounding with measurement error. The
unit variability is not estimable with the other two designs since each experimental unit
is only measured once which makes distinguishing the unit effect from the measurement
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error impossible. The arrow direction is reversed on each replication so that the dyes
are balanced for every treatment pair combination whenever there is an even number
of blocks. An even number of blocks was not forced to occur when calculating the
number of blocks for the loop design. Design B once again uses three experimental
units per block, but this design only allows each experimental unit to be measured once.
Since there is an odd number of treatments, this forces experimental units from different
blocks to be paired together, called across block pairings. A detail to note about Design
B is that each pairs of treatments can only be both dye balanced and across block
balanced, when there are blocks in increments of twelve. When comparing this design,
this was not constrained to occur. Also for Design B, the blocking shown could not be
introduced by the lab constraints mentioned previously since an entire array must be
made at one time not allowing across block pairings. Design C is simpler in that only
one pair of treatments is measured within a block. With this design, it takes at least
three blocks for each treatment pair to be measured and six for the dyes to be balanced
among the treatment pairs. Since only one array is measured in each block, Design C
causes confounding between the block and array effects as well as the unit effect and
measurement error. In this example, treatment pairs were forced to be balanced, so
blocks were added in groups of three.
Code was created in R, to calculate the number of blocks to use for each design after
receiving the experiments total funds along with the cost of arrays and experimental
units. The specific constraints mentioned previously were enforced for each design. The
number of blocks could differ for the experimental designs since the total cost of the
experiment was the only limit.
The three designs were compared at various cost ratios using parameter estimate sets
from an actual experiment that was performed using the loop design. The experiment
enabled the estimation of all four of the variance components necessary to compare the
designs of interest. Since a small adjustment to the total funds available could result
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in an additional block for one design but not the other two, the designs were compared
multiple times with varying amount of total funds for each array and experimental unit
cost. This process was repeated for many different array and experimental unit cost
ratios.
Figure 8 Cost comparison of designs A and C. Blue pyramids represent the
locations where Design A had a lower standard error for treatment
differences. Red stars indicate the locations where Design C had
a lower standard error.
The first comparison of the three designs assumed an equal cost between the exper-
imental units and arrays. Saying that a design tested as the best for a cost ratio means
that it had the minimum standard error for tests of variety differences the majority of
the time. With Design B, the standard errors could differ depending upon which pair
of the three varieties were being tested for a difference. This only occurred when the
number of inter-block treatment comparisons was not balanced. Although this was not
the case for the other two designs, standard errors were compared for each of the three
variety pair differences. However, Design B was never chosen to be the best design under
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these conditions. So for this discussion, each design was compared using one standard
error and the minimum of the three standard errors was used for Design B. Under these
constraints, the loop design (A), always tested to be the best design to use regardless
of the total funds available. For example, if the total funds available were 50 times
either the cost of the experimental units or arrays, then Design A would be favored
to use since it has a smaller standard error than Design B approximately 76% of the
time. Design A would also have a smaller variance than Design C 83% of the time.
The median of the ratio, s.e.B/s.eA is approximately 1.09 and approximately 1.08 for
s.eC/s.eA. A histogram of the 3730 values of s.eC/s.eA is shown in Figure 9. Figure 8
shows that Design C would only be preferred in cases where the unit variability is large
relative to the measurement error and slide variability. The same was also true when
comparing Design A to Design B. This is not surprising since every experimental unit is
measured twice with the loop design, reducing the number of units used in relation to
the competing designs. These results are only with respect to the variance component
values obtained from the experiment mentioned previously.
Figure 9 Histogram of the ratio of the treatment difference standard errors
for Design C to A.
If the cost of the experimental unit was small relative to the cost of the array,
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the optimal design to use would change. Under the same variability conditions as the
previous example, but with now having the microarray costing five times as much as the
experimental unit, either Design B or Design C would be the best choice. Both Design
B and Design C’s standard error would be lower than Design A’s more than 66% of the
time. The median of the ratio of s.eC/s.eA was approximately .95. The relationship
between unit variability and design selection, shown in Figure 8, still is true. The only
difference is that with this cost relationship, it does not take as large of a unit effect to
choose either Design B or C. For comparing Design C to Design B, Design C’s standard
error was less than Design B’s only 50.08% of the time and had a median ratio of .9998.
Although both B and C would be selected over A under these conditions, neither show
evidence of being better than the other. However, Figure 10 shows that an increase
in slide variability relative to measurement error would make choosing Design C more
likely. If the opposite conditions were to occur then Design B would most likely be the
best selection. An increase in unit variability also increases the likelihood of choosing
Design B over Design C slightly. The block effect, which is not shown in any of the
figures, was investigated but appears to have very little impact upon design selection.
When accounting for cost, the loop design is the favorable choice a large amount
of the time. If the cost design comparison was also performed using a method which
requires calculating the differences for each array (Glonek and Solomon, 2004; Yang
and Speed, 2002 ), the loop design could not be considered. Since after calculating the
differences, there is still correlation amongst the observations, this design would have to
be eliminated. Design B could be investigated if there was not a block effect. Not using
mixed model comparisons could eliminate the optimal design from consideration a large
amount of the time.
Accounting for the costs can have a valuable impact upon experimental design selec-
tion. However, it is not easy to make a standard rule for how costs should be accounted
for. Every experiment could have different costs that could change which design is se-
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Figure 10 Cost comparison of Design’s B and C. Blue pyramids represent
the locations where Design B had a lower standard error for treat-
ment differences. Red stars indicate the locations where Design
C had a lower standard error.
lected. For example, there could be a block cost. An example would be an experiment
where offspring where treated and measured making them the experimental unit. There
would be correlation amongst the siblings, causing blocking by the parents. Now, De-
signs A and B would both use 3 offspring per litter while Design C would only use 2.
This would create a need for more litters with Design C causing an increase in expendi-
ture. Another possible cost consideration could occur when an experiment is intended
to study transgenic organisms. Transgenic organisms will often cost much more than
nontransgenic organisms. Taking this into consideration could change the designs to
consider and the optimal design to use. Considerations such as these would need to be
accounted for in the cost comparisons which make standard methods difficult to present.
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6 Considerations
A possible problem with this method is that when comparing designs relative to a test
of interest using an F-test, not only can the variability change but also the denominator
degrees of freedom. This should be considered as well since one design could have
a slightly smaller expected variance but the alternate design could also have smaller
denominator degrees of freedom which could cancel or even reverse which model is
preferred. One option to account for this is to use Fisher’s relative efficiency (Fisher,
1960) to compare designs instead of the variances alone. Fisher’s relative efficiency differs
from the usual ratio of design variances by also accounting for the degrees of freedom.
The formula is [
(1 + dfDes1) (3 + dfDes2)
(3 + dfDes1) (1 + dfDes2)
]
∗
(
V arDes1
V arDes2
)
where V arDesi indicates the variance of the estimator of the parameter of interest for
design i. A drawback to this method is that the impact of the difference in denominator
degrees of freedom is being estimated.
To exactly account for the difference in denominator degrees of freedom, a method
described by Stroup (2002) for power tests could be used instead. This method is de-
scribed using the PROC MIXED procedure on SAS (SAS Institute, Cary, NC) although
the SAS program is not required for this test. This was also discussed for use in microar-
ray experimental designs comparisons recently (Rosa et al., 2005). It is assumed that
the model can be written as Y = Xβ + Zγ +  with  ∼ N(0,R) and γ ∼ N(0,G) with
Cov(,γ)=0, and testing the null hypothesis of K ′β = 0, with the assumption that K ′β
is estimable. Stroup’s method requires knowledge of X,K, and V where V = ZGZ ′+R.
All of these can be obtained from information about the experimental design and esti-
mates of the variance components for use in the design comparison. It is assumed that
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the null hypothesis is being tested using
Fˆrank(K),v =
(
K ′βˆ
)′ [
K ′
(
X ′Vˆ −1X
)−1
K
]−1 (
K ′βˆ
)
rank(K)
which will follow, or approximately follow, the F distribution with rank(K) numerator
degrees of freedom and v denominator degrees of freedom. When the test statistic does
not truly follow the F distribution, the denominator degrees of freedom can be approxi-
mated using either the Satterthwaite (1946) or Kenward-Roger (1997) methods, among
others. When the null hypothesis is false, this test statistic will follow, or approximately
follow, the F distribution with non-centrality parameter λ, where
λ = (K ′β)′
[
K ′
(
X ′V −1X
)−1
K
]−1
(K ′β) .
Experimental designs are then compared based upon their power to pick up a difference
of the magnitude desired. This is done by first calculating Fcrit by P (Frank(K),v,0 >
Fcrit) = α where α is the desired Type 1 error rate. The power to find the difference of
interest is then calculated by P (Frank(K),v,λ > Fcrit) by using the proper values of X,V, v
and λ. The “best” design is then chosen by which has more power for the majority of
the parameter value sets considered.
Stroup’s method does allow accurate consideration of both the covariance parameter
values and the degrees of freedom. A benefit to this method is that quite often with
mixed model designs, the test being performed is not truly an F test but is approximated
by the F distribution. To do this, the denominator degrees of freedom are necessary to
estimate. Stroup’s method makes this easy by simply indicating in the MIXED procedure
the method of estimating the denominator degrees of freedom that is desired to use. One
drawback is that the magnitude of the power increase is dependent upon the difference
value that is chosen. That is not a problem when comparing standard errors however.
When comparing designs by the standard errors, the magnitude is meaningful and may
have a significant impact when comparing closely competing designs.
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7 Conclusion
The number of microarray experiments being performed keeps growing every day.
The information obtained aids in the understanding of organisms, organs, and disease,
amongst many other areas of research. Using mixed model analysis for microarray
experiments can increase the power obtained relative to analyzing array differences.
Lessening the variability of the tests of interest with mixed model analysis may enable
one to find important genes which otherwise would not be found.
Proper experimental design selection requires accounting for how the data is to be
analyzed. If mixed model analysis is to be used, that should also be accounted for in the
design selection process. The variance equation complexity makes simulation a beneficial
alternative when comparing mixed model designs. This does make choosing a design
more difficult because there may no longer be a specific set of designs that should be
used for all experiments with specific treatment structures. Design selection depends
upon the distribution fo the true values of the variance components. This can make
design selection additionally difficult and increases the benefits of acquiring information
from similar experiments previous to the choice of experimental design.
Various costs can also make a large impact upon design selection. In cases where there
is a specific amount of money dedicated to the microarray phase of an experiment, the
optimal design can rely heavily upon the costs of the arrays and experimental units along
with the distribution of variance components. Mixed model design comparisons allow
all of these factors to be considered in selecting a design. Using all of this information
can make a substantial increase in power for an experiment.
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Identification of Differentially Expressed Functional Categories
in Microarray Studies Using Nonparametric Multivariate
Analyses
Justin C. Recknor, Dan Nettleton, and James Reecy
Abstract
Tests of differential expression across groups of genes, within a func-
tional category, are performed using a method motivated by Barry, Nobel,
and Wright (2005). Rather than comparing marginal distributions on a
gene-by-gene basis across treatment groups, we use a test statistic that
can detect general changes in multivariate distributions across treatment
groups. Resampling-based methods and multiple-testing adjustments are
used to obtain simultaneous inference for multiple groups of genes. Re-
sults are visualized on a directed acyclical graph, and new methods for
pinpointing genes of greatest interest are provided.
1 Introduction
Advances in science have enabled researchers to measure a large number of genes’
transcription expression levels simultaneously by use of microarrays. The level of ex-
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pression of a substantial proportion of an organism’s entire genome can be measured on
a single array or slide. Microarray experiments are designed to find genome expression
differences between at least two classes, often to get a better understanding of an im-
pairment in hopes of finding a remedy. This process can empower scientists to obtain
valuable information about diseases, animal breeds, and other biological interests.
Experiments can be performed using oligonucleotide microarrays to measure gene
expression levels for a biological subject. To perform an experiment, mRNA is extracted
from a subject and labeled with a fluorescent dye. The sample is then placed on an
array containing a large number of probes. A probe is a short sequence of cDNA that
is complementary to a unique region of the mRNA for a specific gene which will make
the according mRNA sample bind to it. There are many probes, often 25, placed on an
array for one gene resulting in multiple measurements of the same gene on one array.
The measurement values for each probe are obtained by applying a laser to them and
measuring the fluorescent signal returned. These gene measurements come from multiple
locations upon the slide where the probes are located. Procedures such as MAS 5.0
(Affymetrix) and Robust Multi-array Average (RMA) (Irizarry et al., 2003) are often
used to condense the data down to one measurement for each gene. The resulting data
is then analyzed on a gene-by-gene basis.
Researchers obtain a vast number of measurements for the organism of interest. Since
analysis is performed individually for each gene, one experiment will usually consist of
20,000 or more tests. This leaves a very large number of statistics or p-values to deal
with. If one was to just declare every gene with a p-value less than a chosen threshold
significant, the study could suffer from a high number of false conclusions. To prevent
this, the p-values are often adjusted for the multiple comparisons using a method such
as the Bonferroni adjustment to control the Type I error rate. This method of p-value
adjustment is designed to control the family-wise error rate which means to prevent
any of the null hypotheses from being incorrectly rejected. When working with a large
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number of tests, as in microarray experiments, controlling the family-wise error rate can
result in very conservative results. In order to have a high level of confidence in every
null hypothesis rejected, a large number of differentially expressed genes must also go
undetected.
To prevent overly conservative results, false discovery rates are used in microarray
experiments as an alternative (Benjamini and Hochberg, 1995; Storey and Tibshirani,
2003). Instead of controlling the probability that all the null hypotheses rejected are
truly false, the FDR estimates the expected proportion of the null hypotheses which are
rejected that are actually true. For example, if one was to use a 5% FDR and there
were 100 significant genes at that level, then the null hypothesis would be expected to
be true for approximately 5 of the genes. This method usually allows for a much larger
number of null hypotheses to be rejected.
Using either the family-wise error rate or the false discovery rate on a successful
experiment, leads to a list of genes that are declared to be differentially expressed for a
study. Often scientists are left with a very large number of genes to interpret. Deciding
upon the meaning of, and further testing a proportion of thousands of genes can be a
very daunting task. On the other hand, after accounting for the multiple comparisons
for each gene, microarray experiments can also lead to a very small number of genes
testing significant. This list could contain genes with very large fold changes that do
not appear to be biologically related. Even worse, genes with very small fold changes
which seem to have little biological meaning may test significant with very low p-values
due to small variance estimates. This happens often, largely due to a large number of
tests with small sample sizes which makes these results difficult to trust. Regardless of
any of these situations, only the genes with extreme values of test statistics are chosen
for further study.
Often investigators are looking for networks, consisting of many genes, to explain
biological differences. There could be a family of genes, many with relatively small
70
fold changes, that could be important to the study. For example, a group of genes all
working together for the same biological purpose could all experience small fold changes.
All of the genes changing expression could have a large impact upon their common task.
This family of genes would rarely be found using the usual “gene by gene” statistical
procedures and yet could be very important to the study.
Even if a network of genes is discovered in a study, other researchers may have a
difficult time finding the published results due to use of differing terminology. To reduce
the occurrence of this problem, the Gene Ontology (GO) Consortium was established
(Gene Ontology, 2000). GO unites scientists’ vocabularies by making concise annota-
tions of gene functions that are independent of species. GO contains three separate
ontologies pertaining to gene functions. These are the gene’s molecular function, its
biological process, and the cellular compartment that it acts within. A gene’s molecular
function and its biological process can be difficult to separate, but the biological process
is considered more broad and must have more than one step. Each ontology consists of
a hierarchy of terms that start with broad classifications and go to specific terms. This
system does resemble a phylogenetic tree except that one node can have more than one
parent. Genes of more than 87,000 species already have GO annotation and the library
keeps expanding as the research progresses.
Microarray experiments alternatively can be analyzed by a category, such as a GO
classification, instead of by the gene as is usually performed. Analyzing microarray
experiments with the help of GO groupings is not a new area of study. Many papers
have been published discussing different methods for testing GO annotations. Many
of these consist of looking at the quantity of significant genes within each annotation
(Beibarth and Speed, 2004; Berriz et al., 2003; Shah and Fedoroff, 2004). A problem
with these methods is that they rely upon what group of genes are considered to have
“significantly different” expression levels among the treatments. Also, these methods
would not be likely to find gene annotations that consist of many genes having relatively
71
small fold changes as discussed earlier. Another possible defficiency of these methods
are that they often use tests which require independence of the observations to be valid
such as Fisher’s Exact Test and hypergeometric probabilities.
Other methods have been proposed that do not have these same weaknesses, one
of which is called the Significance Analysis of Functional categories in gene Expression
studies (SAFE) (Barry et al., 2005). The SAFE method entails calculating test statistics
of interest from the normalized data for each gene. A global statistic is then calculated
by measuring the difference between the distribution of statistics within a group (such
as a GO annotation) to the distribution of statistics outside of a group using a method
such as the Wilcoxon rank sum test statistic or Kolmogorov-Smirnov test statistic. The
treatment labels are then permuted by the samples to maintain the correlation between
the genes and the global statistics are once again calculated. P-values are computed
by measuring the extremity of the actual global statistic versus the permutated values.
The groups whose distributions differ the most from the rest of the population are then
selected.
An alternative method is called the Gene Set Enrichment Analysis (GSEA) (Sub-
ramanian et al., 2005). The GSEA method requires first calculating a test statistic for
every gene in the study. The statistics are then ordered from least to greatest. Starting
with the smallest ordered statistic, a category is given a positive score if it contains that
gene, and a negative score if it does not. This is repeated orderly for all the statistics,
keeping a running-sum for each category. Every category is then given an enrichment
score for its maximum deviation from zero along the process. The enrichment scores are
normalized to compensate for different category sizes. P-values are obtained for each
category by assuming the enrichment score corresponds to a weighted “Kolmogorov-
Smirnov-like” statistic.
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2 Multi-Response Permutation Procedure (MRPP)
Multiresponse Permutation Procedures (MRPP) are described in a recent book by
Mielke and Berry (2001) which addresses the testing of hypotheses by use of distances
between points. MRPP entails measuring the average within treatment distance which
gives a measure of the variability within treatments by calculating the average of all
pairwise distances between observations within each treatment group. Tests for treat-
ment effects are then performed by comparing the average within treatment distance
of the original sample to values obtained through permutation of the treatment labels.
P-values are achieved using ∑P
i=0 I(D¯i ≤ D¯0)
P + 1
(1)
where D¯i is the average within treatment distance of the i
th permutation and P represents
the number of permutations used. D¯0 is the average within treatment distance received
from the original data.
2.1 MRPP in Microarray Analysis
The MRPP method can also be used to test gene categories for evidence of different
expression patterns between treatments. Categories can be overlapping, or genes may
appear in multiple categories. This is important because multiple GO annotations can
be attributed to a single gene which can create high correlations among the categories. It
is required that categories be determined a priori, or in a manner unrelated to the data
from the experiment to receive valid results. The data from the experiment is assumed
to have been normalized previously and laid out in a G × N matrix. G indicates the
number of genes measured. N , or number of columns, is equal to the number of samples
measured in an experiment. Since independence of the observations is required, the
number of samples must also equal the number of experimental or observational units
in the experiment. The number of treatments, or varieties, being analyzed is indicated
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by T. For the ith treatment, there are ni samples measured such that
∑T
i=1 ni = N .
For each category, a subset of the original G×N matrix of size Gc ×N is obtained
where Gc is the number of rows, or genes, within category c. Each column consists of
measurements from one experimental unit so each column of this matrix can be viewed
as one vector in Gc dimensional space. A multidimensional aspect of the MRPP analysis
is then used. By associating each column with the appropriate treatment, the average
within treatment distance of these vectors is calculated using
D¯ =
T∑
i=1
ni
N
(∑ni−1
j=1
∑ni
k=j+1 dijk∑ni−1
x=1 x
)
(2)
where dijk is the distance between replications (vectors) j and k for treatment i. The
denominator results from there being a total of
ni
2
 = ∑ni−1x=1 x column pairs within
each treatment group. The distance between samples, or columns, is computed using
Euclidean distance, or
dijk =
√√√√ Gc∑
l=1
(yijl − yikl)2
where yijl indicates the measurement value for treatment i, repetition j, and gene l.
This method of calculating distances is recommended by Mielke and Berry(2001) and is
used in all examples shown although other distance measures could be used if desired.
P permutations of the treatment labels amongst the columns are performed cal-
culating the average within treatment distance (D¯i) for each one. All of the possible
permutations should be used but even a modest number of replications per treatment
make this too large for realistic use. A random subset of all of the possible permutations
can be used as a practical approximation. This entire process is performed for each
category using Equation 1 to obtain p-values. The null hypothesis (H0) for this test is
equal probability of occurrence for each of the possible R allocations of the N columns
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into the T categories. The total number of possible allocations is
R =
N !∏T
i=1 ni!.
(3)
2.2 P-values
Often, the number of gene categories being investigated can be large. This creates
a need for p-value adjustments in order to keep the Type I false discovery rate at an
acceptable level. When working with GO annotations, many categories consist of very
high proportions of the same genes, some even containing the exact same genes causing
high levels of correlation between categories. Research has shown the method of esti-
mating the FDR presented by Benjamini and Hochberg (1995) to give reliable results
under certain correlation conditions (Benjamini and Yekutieli, 2001). However, it was
also shown that this method gave conservative results under certain highly positive cor-
relation conditions. To eliminate this concern, another method was used as described in
the SAFE method paper (Barry et al., 2005). This was an FDR estimation procedure
created by Yekutieli and Benjamini (1999) which is specially designed for use with cor-
related test statistics. This method requires resampling so the average within treatment
distance (D¯) must be retained for every permutation of every category. This creates a
P (1) × C matrix of average within treatment distances (D¯pc) where P (1) = P + 1 with
P being the number of permutations performed. The first row contains the distances
obtained from the observed data. This matrix of distances must be converted to a P ×C
matrix of p-values where
pp(1)c =
1
P (1)
P (1)∑
x=1
I
(
D¯xc ≥ D¯p(1)c
)
.
Yekutieli-Benjamini’s estimate of the FDR is
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F̂DRY B(p) = min
c:pc≥p
 1
P (1) − 1
P (1)∑
x=2
(
Vˆx(pc)
Vˆx(pc) + Sˆx(pc)
)
in which
Vˆx(p) =
C∑
i=1
I(pxi ≤ p),
and
Sˆ(p) = Vˆ1(p)−
( 1
P (1) − 1
) P (1)∑
x=2
C∑
i=1
I (pxi ≤ p)
 .
Through simulation, this method was shown to increase power while maintaining control
over the false discovery rate even in cases of highly correlated observations. The F̂DRY B
was derived following a resampling based method for controlling the family wise error
rate proposed by Westfall and Young (1989). When working with a smaller number of
categories, controlling the family wise error rate may be preferred. Westfall and Young’s
method
̂FWERWY (p) = max
c:pc≤p
 1
P (1)
P (1)∑
x=1
I
(
min
h:ph≥pl
pxh ≤ pc
)
will prevent the overly conservative results obtained by other methods when adjusting
highly positively correlated p-values.
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Figure 1 A plot of expression measurements from two genes. Treatment 1
is shown in blue squares, treatment 2 in red circles. Red and blue
marks on the axes indicate the location of the measurements for
each gene.
2.3 Considerations for Variance Differences Between Genes
A problem can be introduced by unequal variability between the genes when using
the MRPP method to find gene categories with different expression patterns between
the treatments. The gene or genes with larger variability can dominate the test results.
This is shown in Figure 1. Each plot represents a category of two genes from an
experiment with two treatments with ten independent measurements from each. For
both plots, the measurements of Gene 2, which are shown on the vertical axis, have 10
times the variability of the observations of Gene 1. In Plot A, there is total separation
between the observations of each treatment in terms of Gene 1 whose observations are
shown on the horizontal axis colored by treatment. Considering these two genes as an
entire category, the MRPP method of analysis was performed using 499 permutations
and obtained a p-value of .324. Differences between Treatments 1 and 2 for Gene 1
are obscured because of the larger variability of Gene 2 making the MRPP test fail to
find treatment differences for this category. In Plot B, the treatment separation occurs
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for Gene 2 which has the larger variability. There is now total separation between the
treatments, so the p-value of the MRPP test is guaranteed to be 1/(P + 1) where P is
the number of permutations performed showing how more variable genes are allowed to
dominate test results.
Two methods were considered to eliminate this problem. A procedure called Eu-
clidean commensuration was proposed by Mielke and Berry (2001) for eliminating result
domination by variability. Letting yij be the expression measurement for gene i and
sample, or column j, φi is calculated using
φi =
[
N−1∑
j=1
N∑
k=j+1
|yij − yik|v
]1/v
.
The observations in each row are standardized using xij = yij/φi. The resulting data
now has the property that
N−1∑
j=1
N∑
k=j+1
|xij − xik|v = 1 (4)
for all i values and any choice of v making every gene have the same total distance using
Equation 4 between points. This is called Euclidean commensuration when v=1.
A second method was considered which consisted of standardizing the measurements
from a common gene by dividing them by their standard deviation. This ensures that
every gene will have the same variance. This procedure resulted in the same results as
Euclidean commensuration for all analysis ran. Because of this, Euclidean commensu-
ration will just be used throughout the paper.
The data from Figure 1 was transformed using Euclidean commensuration which
made the degree of distance separation the same for both genes. These values are shown
in Figure 2. Performing the MRPP analysis with 499 permutations on the transformed
genes now results in a p-value of 1/500 in both cases, eliminating the dominance of one
gene in the outcome allowing separation to be found in both categories.
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Figure 2 A plot of expression measurements from two genes. Treatment 1
is shown in blue squares, treatment 2 in red circles. Red and blue
marks on the axes indicate the location of the measurements for
each gene.
2.4 Benefits
A loss incurred when analyzing the p-value distribution, or the statistics of the genes,
as used in either the SAFE or GSEA methods, is the information on the multivariate
relationships between the genes in each group. A two dimensional example of this can
be seen in Figure 3. Shown are the expression values of two categories of two genes in
an experiment with two treatments and five replications. Two genes plotted together
indicates that they share a category. When looking at the measurements for Gene 1,
which are shown along the x-axis of plot A, there does appear to be some evidence of
a difference between the treatments. Performing a t-test results in a p-value of .05383.
Gene 2, shown along the y axis, appears to have no difference between the treatments
and its t-test yields a p-value of .5531. For a category of size two the p-value distribution
may not be convincing although when looking at the two dimensional plot of the values,
there does appear to be separation between the treatments. This separation is shown
in the results of the MRPP test, which yields of p-value of .0238. Genes 3 and 4, shown
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on plot B, both appear to have a difference in expression between the treatments and
this is also shown in the resulting p-values for the individual t-tests. The MRPP test
also works in finding these differences yielding a p-value of .0079. This is the minimum
p-value obtainable since there are only 126 possible permutations.
Figure 3 Plots of two categories consisting of two genes. Treatment 1 is
shown in blue squares, treatment 2 in red circles. Red and blue
marks on the axes indicate the location of the measurements for
each gene. The p-values are from t-tests for treatment differences
for that gene.
An additional strong point of the MRPP method is the lack of distributional assump-
tions which are not necessary when calculating multidimensional distances and acquiring
p-values by permutation. This is a valuable asset but it does not aid in separating the
MRPP method from the alternatives discussed earlier, which also use permutation tests.
3 Resampling Based P-value Test Method
A limitation of the MRPP method is the experiments to which the procedure can
be applied. With the multi-response method of analysis, tests for interaction cannot be
obtained. In many studies, the interaction between treatments is the test of interest.
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To satisfy these conditions, the Resampling Based P-value Test (RBPT ) method of
analysis is proposed. This method can also perform tests of treatment differences as
performed previously with the MRPP method.
When testing for treatment differences, the data is assumed to be laid out as men-
tioned previously, in a G×N matrix where G indicates the number of genes measured
and N indicates the number of samples measured. When testing for treatment differ-
ences using the RBPT method p-values are obtained separately for every gene in the
matrix. These values are often achieved using either a t or an F-test. The treatment
labels are then permuted among the samples gathering p-values for every gene and
permutation. Resulting, is a G × (P + 1) matrix of p-values where the first column,
numbered 0, contains the p-values from the original data. Permutation is performed by
the columns to ensure that the correlation structure between the genes is maintained.
When performing all permutations is not feasible, P permutations are selected, allowing
equal probability to each of the possible permutations.
When testing for a difference in expression between treatments for a category the
null hypothesis is, H0 : µi1 = µi2 = · · · = µiT for i = 1, · · · , Gc. This procedure’s
goal is not actually to maximize the power for testing against the null hypothesis of
no treatment mean differences for every gene in a category. Instead the goal is to find
categories where there is evidence of differential expression for a substantial proportion
of the population. The method used in obtaining p-values was created keeping this in
mind. First, the G × (P + 1) matrix of p-values for every gene and permutation is
reduced to a Gc × (P + 1) matrix containing the p-values for every gene in category
c. The 1 × Gc vectors of p-values obtained from every permutation, and the original
data, is condensed to a single value by calculating the median. Other statistics such as
the mean, Fisher’s p-value (
∏Gc
i=1 pi), and Pearson’s p-value (1−
∏Gc
i=1(1− pi)) were also
seriously considered but the median was chosen for it’s robustness to outlying p-values.
We did not want to find categories with a very small group of genes with very small
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p-values. We would rather find categories with many genes with moderately reduced
p-values and using the median enabled this. When H0 is true and the test assumptions
are met the resulting p-values will follow the uniform distribution[0,1]. Under these
conditions, the median would have an expected value of 50%. When H0 is false the
p-values would follow a distribution more concentrated towards zero which would have
an expected median less than 50%. If there were only a couple of genes in the category
for which the null hypothesis was false, little impact would be implied upon the median
statistic for the category. This was a concern since tests receiving small p-values under
biologically questionable conditions are not uncommon in microarray experiments as
described previously. If many genes in a category had moderately reduced p-values, this
would be shown using the median. A graphical representation of the steps of the RBPT
test is shown in Figure 4.
Figure 4 RBPT method. Matrices containing the original data values are
shown in green while matrices of p-values are shown in blue.
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3.1 Testing Interaction
Tests for which the RBPT method can be performed exactly as described previ-
ously using permutations are limited. Adjustments are necessary in order to test for
interaction. Residual bootstrapping is a reasonable alternative which allows for tests
of interaction as shown in Davison and Hinkley (1997). Bootstrapping is similar to
permutation except that the data are sampled with replacement.
TO test for interaction, an alteration must be made to the RBPT method shown in
Figure 4. The only change in this process is in how the p-value matrix is obtained. An
important detail when testing for interaction is that no additional assumptions can be
made regarding the other parameters, such as the main effects. In order to do this, the
main effects must be accounted for in carrying out the bootstrapping. For example, in
an experiment following a completely randomized design with a 2 factorial treatment
structure, the data would first be modeled on a gene-by-gene basis as:
yijk = µ+ αi + βj + (αβ)ij + ijk (5)
where α and β are the treatment main effects and (αβ) is the interaction. The i and j
indicate the treatment levels and k is the replication number. This model would be fit
to the data for every gene keeping the p-values for the test of interaction along with the
residuals. Next, each gene is once again analyzed using the model
yijk = µ+ αi + βj + ijk (6)
in which α and β remain the treatment main effects and this time keeping the predicted
values for every observation. Bootstrapping is performed by randomly sampling from
the columns of the residual matrix obtained using Model 5 with replacement N times.
The sampling is done by the column to preserve the correlation amongst the genes.
This creates a G×N matrix which is added to the matrix of predicted values obtained
83
using Model 6. A p-value is then obtained for each gene using Model 5 to test the
null hypothesis of no interaction. This process is performed P times preserving the
p-values. Through this, the G × (P + 1) matrix shown in Figure 4 is obtained and
the remaining steps are followed accordingly, to get p-values for each category. Each
category is then tested for the null hypothesis of H0 : (αβ)1 = (αβ)2 = · · · = (αβ)T = 0,
for i = 1, · · · , Gc. Once again, this test is not aimed at maximizing the power in
testing against treatment interaction for each gene since the goal is to find categories
with substantial evidence of interaction. This method does enable testing strictly for
interaction through residual bootstrapping while not making assumptions about the
main effects. With some minor restrictions on how the bootstrapping is performed, this
method could also be applied to experiments following a randomized complete block
design.
4 Regulation
In microarray experiments, interest is not only in selecting which genes have signifi-
cant changes in expression levels, but also in the direction of the change. When the gene’s
production is reduced under the treated conditions, that is called down-regulation. The
opposite is called up-regulation. When the MRPP method is used to find gene categories
with difference in expression, only the multidimensional distance between points, and
not the direction, is used in the analysis. When using the RBPT method, up or down-
regulation can be seen in the signs of the t-values. However, these values are not used
in the test. Consequently, a second step is necessary to statistically test for regulation
direction for either method.
Investigating the type of regulation is only applicable to cases where two treatments
are compared. When more than two treatments are being analyzed, only pairs of the
treatments can be considered at a time. To test for regulation, after a category has
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been declared significant the data are reduced to a Gc × N matrix containing only the
measurements corresponding to the genes within the category of interest. For every gene,
t-tests are performed resulting in a Gc × 1 vector of t-values. The number of positive
t-values (t+) is then counted. The treatment labels are then permuted P times between
the N columns. Permutation by the columns is used to preserve the correlation between
the genes as described previously. To test for up-regulation, a p-value is obtained by∑P
i=0 I
(
t+0 ≤ t+i
)
/(P + 1), or the percentage of the times the observed t+ value (t+0 ) is
greater than all of the t+ values obtained through permutation. The p-value for down-
regulation is achieved by
∑M
i=0 I
(
t+0 ≥ t+i
)
/(P + 1). Both tests have a null hypothesis
of equal dispersion of up and down regulated genes.
This test is only applied to categories for which the null hypothesis was rejected.
This test is just meant to give an idea of categories in which there is some form of
regulation. Because of this, no multiple comparison adjustment is made to the resulting
p-values. This test also places no bounds on what kind of a disproportion of up or
down regulation is necessary to test significant. There have been cases where categories
having only 58% of the genes being up-regulated tested significant. This may not be
biologically meaningful but the test results do find an imbalance.
5 Influential Genes
After having performed the analysis and decided upon a group of categories to declare
as being differently expressed between the treatments, researchers might also wish to
identify the genes predominantly responsible for the significant test results to further
their research. This may seem as going full circle because the concentration is now back
onto individual genes. However, the only genes being investigated are contained within
the category of interest. One option would be to simply look at the p-values for each
gene in a category. Simply selecting a false discovery rate for these p-values could give a
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list to investigate. However, this would ignore the relationships between the genes that
could be responsible for the category’s selection.
An alternative, when dealing with two treatment varieties, would be to use Fisher’s
discriminant function (Fisher, 1938). This finds the linear combination of the response
variables which achieves maximum separation between the treatments in standard de-
viation units. Let X(i) be a Gc × ni matrix of observations containing all samples that
received treatment i and all genes in category c. Let X be the horizontal concatenation
of X(1) and X(2). The linear combination which achieves maximum separation between
the treatments is found maximizing
(y¯1 − y¯2)2
s2y
where y1j=aˆ
′X(1)•j and y2j = aˆ
′X(2)•j with j = 1, · · · , n1 and k = 1, · · · , n2. X(i)•j indicates
the vector of responses for sample j which received treatment i. The loadings are
obtained using
aˆ′ =
(
X¯(1) − X¯(2))′ S−1X
where X¯(i) is a 1×Gc vector consisting of the means of X(i) for every gene. S−1X is the
inverse of the covariance matrix ofX. The maximum separation is found using yij=aˆ
′X(i)•j
where aˆ′ contains the loadings for every gene indicating their value in separating the
varieties. These loadings are then used to indicate which genes play the strongest role
in dividing the varieties.
A problem with using this method is the requirement of calculating the inverse of
the covariance matrix (S−1X ). In microarray experiments, the number of genes being
studied is much greater than the number of samples (G >> N) and this is also usually
true for the categories of genes being analyzed (Gc > N). This causes the covariance
matrix needed to compute Fisher’s discriminant function to be singular which makes
it not possible to invert. A shrinkage approach (Schafer and Strimmer, 2005) has been
proposed as a method to overcome this difficulty. By substituting the shrinkage estimate,
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SsX for SX , one is guaranteed that it is positive definite enabling the inverse to be
calculated.
To show the information gained using Fisher’s discriminant function, an example was
created. A small five gene category was made with the first two genes expression patterns
displayed in Figure 5. Genes three through five were randomly simulated following the
standard normal distribution. The data was commensurated and analyzed using the
MRPP method to yield a p-value of .049. To show which genes were the most active
in causing the category’s low p-value, both t-test statistics and the loadings for Fisher’s
discriminant function were obtained for each gene. To make them comparable, the values
were standardized and can also be seen in Figure 5. A gene’s influence on separating the
treatments is indicated by the severity of either its loadings or t-values. The loadings
for genes one and two are more extreme than the t-values correctly indicating the two
genes which had the larger impact in the category test results. This is just a simple
example but the added information obtained from the gene correlations by using Fisher’s
discriminant function enables better selection of contributing genes.
6 Examples
Myostatin is a protein which inhibits the rate of muscular cell growth and differen-
tiation. Cattle with mutations in the gene responsible for myostatin production, such
as the Belgian Blue and Piedmontese, have increased quantities of muscle mass. Under-
standing what other proteins are affected by the suppression of myostatin is of interest
to science. Transgenic mice that had their myostatin gene knocked out were studied
in a recent experiment (Steelman et al., 2006) to study differences in gene expression
caused by myostatin production. The experiment compared the expression levels of the
transgenic mice to that of normal or wild type mice at three time points. The time
points were selected to test the impact of myostatin at both the primary and secondary
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Figure 5 Expression values of genes 1 and 2 from a 5 gene category are
shown on the left. The red triangles indicate Treatment 1 while
the green diamonds indicate Treatment 2. Standardized values
of the loadings from Fisher’s discriminant function are shown in
blue stars for each gene in the plot on the right. The standardized
t-test statistics for each gene are shown in green squares.
stages of muscular tissue formation along with a time of fast muscular growth. This
experiment was performed using oligonucleotide arrays on which only one mRNA sam-
ple could be measured. A total of five mice of each genotype where measured at each
time point. The data used were normalized by MAS 5.0. Additional normalization was
performed by subtracting the slide median from every observation on a slide. This made
every slide have an equal median value of 0.
One of the interests of the study was to find GO annotations which exhibit expression
differences between the transgenic and wild type mice at the time of fast muscluar
growth. GO annotations have a hierarchical structure that ascends to a single point.
Each term can have multiple children but one important difference between a normal
hierarchy and the GO consortium is that one term can have more than one parent.
For the experiment, the GO classification for each gene was obtained from the site
of the company responsible for chip production (www.affymetrix.com). This listing
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often gave multiple annotations for each gene. A gene was considered to be within
all annotations listed as well as the ancestry of all the annotations listed. Since each
ontology is hierarchical to a single GO term, every gene listed within any GO term in
an ontology is also contained in the highest ancestral GO term for that ontology. The
ancestry of each GO term was obtained by use of the GOstats package in R. The analysis
was performed on both the biological process and molecular function ontologies. All GO
terms that contained less than forty genes were omitted as they were when testing the
SAFE method (Barry et al., 2005).
There were a total of ten mice, five of each genotype, whose expression was measured
at the final time point of the experiment. A total of 45,101 different probe sets were
measured with 28,110 of them having been assigned to at least one GO molecular func-
tion category. A total of 341 different molecular function categories were tested because
they met the SAFE method criterion and contained at least forty probe sets. For the
biological process ontology, 24,816 probe sets were contained within 739 categories which
were also tested for evidence of differential expression between the genotypes.
Figure 6 Histogram and box plot of the variance estimates for each probe
set within the molecular function ontology. The variance values
were transformed using the log, base 10. The actual minimum,
median, and maximum values are displayed above the box plot.
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The variability within each probe set analyzed was investigated first. This should
be done as a prerequisite in order to know whether or not standardization or commen-
suration is necessary for the MRPP analysis. Figure 6 displays the distribution of the
variance estimates of each probe set within the molecular function ontology. An upper
quartile of approximately .5 and a lower quartile of approximately .04 of the variances
supports the use of Euclidean commensuration of the data which was performed to
prevent more variable probe sets from dominating test results.
The data were analyzed using both the RBPT and MRPP methods of analysis.
Due to the small number of replications, there were only 126 possible permutations of
the data. Thus, every possible permutation was used in analyzing each GO annotation.
Using the MRPP method resulted in 223 categories testing significant at a false discovery
rate of .006. Because of the possibly high correlation between the categories, the FDR
was calculated using the Yekutieli-Benjaminis method as discussed previously. These
categories all had the minimum p-value of 1/126. With the RBPT test, there were 140
categories with the minimum p-value of 1/126. A comparison of the p-value distribution
of both analysis methods, after taking the log10, is shown in Figure 7. The actual spots
have been jittered slightly to show the quantity at each location. Using the minimum
p-value as a selection criterion, 135 categories were selected by both tests. There were 5
groups found with the RBPT method but not the MRPP method, while there were 88
categories selected with the MRPP test but not the RBPT test.
A plot of all GO categories tested are colored by selection method and are shown
in Figure 8. Each dot in the figure represents one GO annotation. The plot shows
the hierarchical structure of the molecular function GO annotation. As the hierarchy
branches out, the GO terms become more specific. Arrows point to the ancestor from
the descendant. Since there were only two treatments, tests of up and down-regulation
were also performed. GO annotations with p-values ≤ 5% were declared significantly
regulated. Up-regualation indicates an increase in gene expression for the wild type
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subjects. Terms classified as significant and up-regulated are shown in green while
evidence of down-regulation is shown in purple. All up and down-regulated categories
tested significant by both methods except for the only up-regulated category which is
not connected to another one. This annotation only tested significant by the MRPP
method. All terms not testing significant for difference in expression for the treatments
are shown by gray ellipses. The results show a great deal of ancestral consistency in that
almost all categories that test significant have at least one direct ancestor also testing
significant. One possible problem indicated by the hierarchy is that not very many high-
level annotations seem to test significant. It was brought to our attention that there has
recently been some questions raised about the validity of some of the GO annotations for
mice at the higher levels. Both tests were designed assuming a high level of confidence
in the GO annotations used. The defficiencies in GO annotations cannot be corrected
for but could explain the possible inconsistencies.
By reducing the plots down to a smaller section of the hierarchy as in Figure 9, the
specific GO annotations causing the broader terms to test significant can be revealed.
Figure 9 reduces the hierarchy to containing only offspring of annotation “GO:0005215”,
which is transporter activity. There are six different children that test significant. In
order to specify the reason why transporter activity appears to differ between the wild
type and transgenic mice, different children can be followed up to a higher specificity.
For example, one of the sequences is 05215-05342-46943-15171-15179. These terms stand
for transporter activity, organic acid transporter activity, carboxylic acid transporter
activity, amino acid transporter activity, and L-amino acid transporter activity. The
final term can give scientists a specific group of genes pertaining to one task for further
studies and understanding of how this expression change effects muscular cell growth.
Concern could be raised over the percentage of the categories testing significant
by both methods in this example. The RBPT method declared over one third of the
annotations as having significant expression change between the treatments while the
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MRPP method found nearly two-thirds. One reason for this is that with both of these
tests, categories testing significant cause all of their ancestors to also test significant
increasing the number of categories found to have differential expressions patterns. Also,
using a procedure proposed by Nettleton (2006) on the pvalues obtained from analysis
ran on a gene-by-gene basis for genotype differences, the proportion of the population
for which the null hypothesis is false is estimated to be approximately 23%. Taking
both of these factors into consideration, a large number of categories testing significant
should be expected for a data set such as this one.
6.1 RBPT versus MRPP
The RBPT method is similar to both the SAFE and GSEA methods discussed earlier
in that all three require calculating a test statistic for each gene. The main difference is in
how the p-values are then calculated. Both the SAFE and GSEA methods compare the
distribution of the test statistics from a category, to the distribution of the test statistics
from the rest of the population. These procedures find categories whose distribution
differs from the rest of the population. In cases where a large number of genes have
different rates of expression between the treatments, these methods would still find a
small number of categories since testing for population differences. The RBPT method
differs in that each category’s statistic is compared directly with statistics obtained
using either permutation or bootstrapping. The RBPT method is testing for significant
difference in expression between the treatments while SAFE and GSEA are testing for
a difference in expression between the treatments that are different than the rest of the
population.
An advantage of the MRPP method is the reduction in computing time that is
necessary. All the other methods require statistics to be calculated for every gene with
every permutation and this process can be computationally intensive. With MRPP
method, the Euclidean distance is computed for every column in a category data set.
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This requires calculating a total of
ni
2
 distances. The Euclidean distances are easily
computed by first calculating the differences between two vectors and then squaring
those values. The square root of the sum of these values is then calculated taking little
computational time. After the distances have been calculated, all the permutations are
with respect to the distances between samples which reduces the size of the data set
being permuted and computations necessary immensely.
Both the RBPT and the MRPP test appear to get consistent results in that anno-
tations testing significant can be followed up the ancestral tree. The MRPP method
does appear to find a larger number of annotations. A possible explanation for this is
that the MRPP test can find multidimensional separation between the treatments that
involves multiple genes simultaneously. Through simulation it was found that when
using commensuration, just a few genes in the population having different expression
patterns between the treatments will not make a category test significant. However,
if commensuration is not used, large categories can test significant with only one gene
actually having treatment expression differences. Since the median is a robust statistic
to the influence of a small proportion of the sample, the RBPT method appears to never
have this problem through the simulations. A possible weakness the RBPT method is
that it shows difficulty in finding a multidimensional separation of the treatments for
which the MRPP method detects.
7 Conclusion
Testing for expression changes by category aids in the understanding of what aspects
of cell activity are affected by treatment or variety differences. Both methods proposed
use resampling to obtain p-values, eliminating any distributional assumptions. Addi-
tional information is obtained from the multivariate relationship of samples by use of
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the MRPP method. As compared to gene-by-gene analysis methods, the MRPP method
reduces computation time while using information normally discarded. One shortcoming
is the limitation of experimental designs and tests for which this method can be used.
The RBPT method has benefits in being more versatile so it can be an option when
looking for effects like treatment interaction.
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Figure 7 Comparison of p-value distributions for the RBPT and MRPP
tests. The p-values have been log10 transformed. Spots colored
red indicate locations where both p-values were 1/126. Orange
locations indicate spots where the MRPP p-values equal 1/126
but RBPT are greater than 1/126 and blue spots indicate the
opposite. The orange histogram shows the distribution of the
MRPP p-values while the blue histogram indicates the distribution
of the RBPT p-values.
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Figure 8 Plot of the molecular function hierarchy studied. GO annotations
selected by both methods are shown in red. Categories selected by
the MRPP method only are orange and blue nodes were selected
only by the RBPT method. Green annotations tested significant
for up-regulation while down-regulated categories are colored pur-
ple.
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Figure 9 Smaller hierarchy for GO:0005215
99
General Conclusion
This dissertation researched three areas of experimental design and analysis of mi-
croarray experiments. The first paper researched important details about two exper-
imental designs. The second paper proposed a method of design comparison which
compensated for mixed model analysis. The third paper proposed methods of analyzing
microarray data by groups or categories.
For microarray experiments, it was shown that an experimental design called DBWT
is more powerful than the DBWS design when constrained by the number of arrays. This
was shown through variance comparison and an actual experiment. We also proposed
an alternative method of analysis for each design which prevented a possible bias in the
results. Both methods guarantee a uniform distribution of the p-values when the null
hypothesis is true and the assumptions hold.
Mixed model analysis was shown to be more powerful than performing ANOVA on
the array differences. Showing that mixed model analysis should be used, reinforces
selection of designs using the more complicated mixed models. Prior knowledge of the
variance component’s distribution is valuable when using mixed model design compar-
isons since the optimal design depends upon the parameter space of the variance com-
ponents. Because the number of subjects, relative to the number of arrays used varies
for different designs, the number of replications possible for a design can vary by cost
limits. This makes the cost of experimental units relative to the cost of arrays have an
impact upon design selection. We show that cost ratios along with prior knowledge of
the variance components are valuable information when choosing mixed model designs
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that require multiple random effects.
Analysis of microarray experiments can also be performed on groups or categories
of genes instead of on a gene by gene basis. High correlation among the groupings
because of classification of genes into multiple categories is acceptable. We show that
when testing for difference in expression between varieties, additional categories can
be found by comparing the multi-dimensional distances between the samples with the
MRPP method. Using the distances allows discovery of interaction between the genes
to separate the varieties expression patterns. This method finds categories that can’t
be found by using tests of each gene within a category. There are experiments which
are looking to find factors like interaction between the varieties in which the MRPP
method can not be used. For these cases, we propose the RBPT method which uses
statistics that are calculated for every gene in a category. P-values are obtained through
resampling of the columns, or samples, which preserves the correlation between the genes
in the category.
Scientists can also be interested in whether these categories are up or down-regulated
and which genes within the category are changing expression the most. Additional
procedures were proposed to answer these questions which can be performed regardless
of whether the RBPT or MRPP method was used in finding the categories. These
discoveries will aid in biological discoveries of the future through design and analysis of
microarray experiments.
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1 Example Code
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2 Containment Method - Order Dependency
The order of the listing of the random effects can change the denominator degrees
of freedom of the test when using the containment method for PROC MIXED in SAS.
In Figure 2, the exact same data set, simulated in the form of a DBWU experiment, is
analyzed twice using the containment method for estimating the denominator degrees of
freedom. The only change in the model is the order of block and unit(trt) in the random
effect listing resulting in a change in the denominator degrees of freedom.
